Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 1-36346

OXBRIDGE RE HOLDINGS LIMITED

(Exact name of registrant as specified in its charter)

Cayman Islands

98-1150254

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Suite 201

42 Edward Street, Georgetown

P.O. Box 469

Grand Cayman, Cayman Islands

KY1-9006

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (345) 749-7570

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes

☒

☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes

☒

☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes

☐

☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of August 08, 2024; 6,036,579 ordinary shares, par value $0.001 per share, were outstanding.

OXBRIDGE RE HOLDINGS LIMITED

INDEX

		Page

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements	3

	Consolidated Balance Sheets June 30, 2024 (unaudited) and December 31, 2023	3

	Consolidated Statements of Operations Three and Six Months Ended June 30, 2024 and 2023 (unaudited)	4

	Consolidated Statements of Cash Flows Six Months Ended June 30, 2024 and 2023 (unaudited)	5

	Consolidated Statements of Changes in Shareholders’ Equity Three and Six Months Ended June 30, 2024 and 2023 (unaudited)	7

	Notes to the Consolidated Financial Statements (unaudited)	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35

Item 4.	Controls and Procedures	35

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	35

Item 1A.	Risk Factors	35

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36

Item 3.	Defaults Upon Senior Securities	36

Item 4.	Mine Safety Disclosures	36

Item 5.	Other Information	36

Item 6.	Exhibits	36

	Signatures	37

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Balance Sheets

(expressed in thousands of U.S. Dollars, except per share and share amounts)

	At June 30, 2024			At December 31, 2023
	(Unaudited)
Assets
Investments:
Equity securities, at fair value (cost: $1,563 and $1,926)	$	213		$	680
Cash and cash equivalents		3,594			495
Restricted cash and cash equivalents		391			3,250
Premiums receivable		2,118			977
Other Investments		965			2,478
Loan Receivable		-			100
Due from Related Party		63			63
Deferred policy acquisition costs		240			101
Operating lease right-of-use assets		124			9
Prepayment and other assets		113			96
Property and equipment, net		2			4
Total assets	$	7,823		$	8,253

Liabilities and Shareholders’ Equity

Notes payable to noteholders	$	118		$	118
Notes payable to Epsilon/DeltaCat Re Tokenholders		1,239			1,523
Unearned Premium Reserve		2,181			915
Operating lease liabilities		124			9
Accounts payable and other liabilities		374			356
Total liabilities		4,036			2,921

Shareholders’ equity:
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,036,579 and 5,870,234 shares issued and outstanding)	$	6		$	6
Additional paid-in capital		32,921			32,740
Accumulated Deficit		(29,140	)		(27,414	)
Total shareholders’ equity		3,787			5,332
Total liabilities and shareholders’ equity	$	7,823		$	8,253

The accompanying Notes to Consolidated Financial Statements are an integral

part of the Consolidated Financial Statements.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Operations

(Unaudited)

(expressed in thousands of U.S. Dollars, except per share amounts)

	2024			2023			2024			2023
	Three Months Ended June, 30						Six Months Ended June 30,
	2024			2023			2024			2023

Revenue
Assumed premiums	$	2,379		$	2,196		$	2,379		$	2,196
Change in unearned premiums reserve		(1,815	)		(2,013	)		(1,266	)		(2,013	)

Net premiums earned		564			183			1,113			183
SurancePlus management fee income		312			300			312			300
Net investment and other income		65			79			126			168
Interest and gain on redemption of loan receivable		-			-			41			-
Unrealized (loss) gain on other investments		(825	)		124			(1,513	)		505
Change in fair value of equity securities		(72	)		5			(160	)		81

Total revenue		44			691			(81	)		1,237

Expenses
Policy acquisition costs and underwriting expenses		62			20			122			20
General and administrative expenses		566			677			1,054			1,081

Total expenses		628			697			1,176			1,101

(Loss) Income before income attributable to noteholders and tokenholders		(584	)		(6	)		(1,257	)		136

Income attributable to noteholders and tokenholders		(237	)		(79	)		(469	)		(79	)

Net (loss) income	$	(821	)	$	(85	)	$	(1,726	)	$	57

(Loss) income per share
Basic and Diluted	$	(0.14	)	$	(0.01	)	$	(0.29	)	$	0.01

Weighted-average shares outstanding
Basic and Diluted		6,010,561			5,870,234			6,007,868			5,863,973

The accompanying Notes to Consolidated Financial Statements are an integral

part of the Consolidated Financial Statements.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(expressed in thousands of U.S. Dollars)

	2024			2023
	Six Months Ended
	June 30,
	2024			2023
Operating activities
Net (loss) income	$	(1,726	)	$	57
Adjustments to reconcile net(loss) income to net cash used in operating activities:
Stock-based compensation		106			109
Depreciation and amortization		2			3
SurancePlus management fee income		(312	)		(300	)
Change in fair value of other investments		1,513			(505	)
Change in fair value of equity securities		160			(81	)
Interest and gain on redemption of loan receivable		(41	)		-
Change in operating assets and liabilities:
Accrued interest and dividend receivable		-			(7	)
Premiums receivable		(1,141	)		(1,672	)
Due from related party		-			(54	)
Deferred policy acquisition costs		(139	)		(221	)
Prepayment and other assets		(17	)		29
Losses payable		-			(1,073	)
Other liablities Cat Re Tokenholders		(1,441	)		79
Unearned premiums reserve		1,266			2,013
Accounts payable and other liabilities		18			9

Net cash used in operating activities	$	(1,752	)	$	(1,614	)

Investing activities
Purchase of property and equipment		-			(5	)
Proceeds from redemption of loan receivable		141			-
Proceeds from sale of equity securities		307			-
Net cash provided by (used in) investing activities	$	448		$	(5	)

Financing activities
Proceeds from issuance of ordinary shares		75
Partial redemption of notes payable to noteholders		-			(98	)
Prepaid offering costs		-			(2	)
Net proceeds from the issuance of Epsilon/Delta Cat Re tokens		1,469			1,280
Net cash provided by financing activities	$	1,544		$	1,180

		(continued)

The accompanying Notes to Consolidated Financial Statements are an integral

part of the Consolidated Financial Statements.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Cash Flows, continued

(Unaudited)

(expressed in thousands of U.S. Dollars)

	2024		2023
	Six Months Ended
	June 30,
	2024		2023

Cash and cash equivalents, and restricted cash and cash equivalents:
Net change during the period		240		(439	)
Balance at beginning of period		3,745		3,928

Balance at end of period	$	3,985	$	3,489

Non-cash investing activities
Right-of-use lease assets obtained in exchange for operating lease liabilities	$	124	$	-

The accompanying Notes to Consolidated Financial Statements are an integral

part of the Consolidated Financial Statements.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Changes in Shareholders’ Equity (unaudited)

Three Months and Six Months Ended June 30, 2024 and 2023

(expressed in thousands of U.S. Dollars, except share amounts)

	Shares		Amount		Capital		Deficit			Equity
	Ordinary Share Capital				Additional Paid-in		Accumulated			Total Shareholders’
	Shares		Amount		Capital		Deficit			Equity

Balance at December 31, 2022		5,769,587		6		32,482		(17,499	)		14,989
Net income for the period		-		-		-		142			142
Stock-based compensation		-		-		54		-			54
Issuance of restricted stock		96,647		-		-		-			-
Balance at March 31, 2023		5,866,234		6		32,536		(17,357	)		15,185
Net loss for the period		-		-		-		(85	)		(85	)
Stock-based compensation		4,000		-		55		-			55
Balance at June 30, 2023		5,870,234		6		32,591		(17,442	)		15,155

Balance at December 31, 2023		5,870,234		6		32,740		(27,414	)		5,332
Net loss for the period		-		-		-		(905	)		(905	)
Stock-based compensation		-		-		72		-			72
Issuance of restricted stock		136,427		-		-		-			-
Balance at March 31, 2024		6,006,661		6		32,812		(28,319	)		4,499
Balance		6,006,661		6		32,812		(28,319	)		4,499
Net loss for the period		-		-		-		(821	)		(821	)
Net income (loss)		-		-		-		(821	)		(821	)
Stock-based compensation		-		-		34		-			34
Issuance of ordinary shares		29,918		-		75		-			75
Balance at June 30, 2024		6,036,579		6		32,921		(29,140	)		3,787
Balance		6,036,579		6		32,921		(29,140	)		3,787

The accompanying Notes to Consolidated Financial Statements are an integral

part of the Consolidated Financial Statements.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

1. ORGANIZATION AND BASIS OF PRESENTATION

(a) Organization

Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. The Company directly owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. The Company also indirectly owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company also indirectly owns 100% of the equity interest in SurancePlus, an entity incorporated as a business company on December 19, 2022 under the laws of the British Virgin Islands to issue digital securities. The Company and it’s subsidiaries (collectively “Oxbridge Re”) provide the following: SurancePlus; is a Web3-focused subsidiary that currently leverages blockchain technology to democratize access to high-return reinsurance contracts via digital securities. Oxbridge Reinsurance Limited; is a licensed reinsurance subsidiary that provides reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States; Oxbridge Re NS is a licensed reinsurance SPV/side car that provides third-party investors with access to reinsurance contracts with returns uncorrelated to the financial markets. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, George Town, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

Below is an organizational chart of the Company.

(b) Basis of Presentation and Consolidation

The accompanying unaudited, consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s consolidated financial position as of June 30, 2024 and the consolidated results of operations and cash flows for the periods presented. The consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ended December 31, 2024. The accompanying unaudited consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2023 included in the Company’s Form 10-K, which was filed with the SEC on March 26, 2024.

Uses of Estimates: In preparing the interim unaudited consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods.

Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. In addition, accounting policies specific to valuation of investments involve significant judgments and estimates material to the Company’s consolidated financial statements. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.

The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.

All significant intercompany balances and transactions have been eliminated.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

SurancePlus Inc’s incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the EpsilonCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

Investments: The Company from time to time invests in fixed-maturity debt securities and equity securities, and for which its fixed-maturity debt securities are classified as available-for-sale. The Company’s available for sale debt investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At June 30, 2024 and December 31, 2023 the Company did not own any fixed maturity debt securities.

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

Level 1	Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

Level 2	Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and

Level 3	Inputs that are unobservable.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Fair value measurement (cont’d)

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity debt securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.

Offering Expenses:. During the six-month period ended June 30, 2024, the Company recognized in the consolidated statements of operations $140,000 of offering expenses in relation to the offering of Epsilon Cat Re digital securities issuable by the Company’s subsidiary, SurancePlus Inc. (See Note 6).

In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $6.3 million from time to time. In accordance with prospectus of SurancePlus Inc., the Company intends to offer and sell its EpsilonCat Re digital securities having an aggregate price of up to $5 million. Reclassification of prepaid offering costs to additional paid-in capital will occur upon successful drawdown of an offering.

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

Loss experience refund payable: Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired; in which case the premium adjustments are fully earned when assumed.

Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

Unearned Premiums Ceded: The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

Ceded premiums are written during the period in which the risk is incepted and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at June 30, 2024 or December 31,2023.

Uncertain Income Tax Positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at June 30, 2024.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

(Loss) Earnings Per Share: Basic (loss) earnings per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the periods presented. Diluted (loss) earnings per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

Share-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility.

Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expenses related to all awards is included in general and administrative expenses.

Accounting Updates:

From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective will not have a material effect on its consolidated financial position or results of operations upon adoption.

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

3. CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

	At June 30,		At December 31,
	2024		2023
	(in thousands)

Cash on deposit	$	3,594	$	495
Restricted cash held in trust		391		3,250
Total	$	3,985	$	3,745

Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with Truist Bank, and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

4. INVESTMENTS

The Company from time to time invests in fixed-maturity debt securities and equity securities, with its fixed-maturity debt securities classified as available-for-sale. At June 30, 2024 and December 31, 2023, the Company did not hold any available-for-sale securities.

There were no sales of equity securities for three months ended June 30, 2024, nor for the three and six month periods ended June 30, 2023. Proceeds received, and the gross realized gains and losses from sale of equity securities, for the six month period ended June 30, 2024 are as follows:

Gross

proceeds

Realized

from sales

Gains

Losses

($ in thousands)

Six Months Ended June 30, 2024

Equity securities

307

Other Investments

On August 7, 2023, OXAC held an extraordinary general meeting at which the business combination with Jet Token, Inc. was approved by OXAC shareholders. In conjunction with the business combination, OXAC was redomesticated as a Delaware entity, and changed its name to Jet.AI Inc. The business combination was closed on August 10, 2023, and on August 11, 2023, OXAC common stock and warrants began trading on the Nasdaq Global Market under the new ticker symbols JTAI and JTAIW.

The Company’s beneficial interests in Jet. AI’s ordinary shares, public warrants and Extension Loan are recorded at fair value and are classified in “Other Investments” on the consolidated balance sheets. The fair value calculation of the Company’s beneficial interest in Jet.AI’s ordinary shares and public warrants is dependent on the observable trading prices of JetAI’s Class A shares and public warrants. The fair value calculation of the Company’s beneficial interest in the Extension Loan is estimated to be the pro-rata original principal amount of the Extension Loan due to the short-term nature.

The Sponsor holds 2,875,000 ordinary shares, 575 Series A-1 preferred shares with purchase price of $1,000 each, along with the 4,897,500 warrants. One of the Company’s executive officers is an independent member of Jet.AI’s board.

As a result of the re-measurement of our investment in Jet.AI, we recognized for the three and six months ended June 30, 2024, an unrealized losses of $825,000 and $1,513,000 respectively within our consolidated statements of operations.

Other investments as of June 30, 2024 and December 31, 2023 consist of the following (in thousands):

SCHEDULE OF OTHER INVESTMENT

	June 30, 2024			December 31, 2023
Jet.AI. Series A-1 Preferred Shares	$	285		$	285
Jet.AI common stock		680			2,193
Total	$	965		$	2,478

Beginning of year		2,478			11,423
Unrealized loss on investment in affiliate		(1,513	)		(8,945	)
End of year	$	965		$	2,478

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

4. INVESTMENTS (continued)

Assets Measured at Estimated Fair Value on a Recurring Basis

The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of June 30, 2024 and December 31, 2023:


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of June 30, 2024	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	3,594	$	-	$	-	$	3,594

Restricted cash and cash equivalents	$	391	$	-	$	-	$	391

Other investments	$	680	$	-	$	285	$	965

Equity securities	$	213	$	-	$	-	$	213

Total	$	4,878	$	-	$	285	$	4,878


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of December 31, 2023	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	495	$	-	$	-	$	495

Restricted cash and cash equivalents	$	3,250	$	-	$	-	$	3,250

Other investments	$	2,193	$	-	$	285	$	2,478

Equity securities	$	680	$	-	$	-	$	680

Total	$	6,618	$	-	$	285	$	6,903

There were no transfers between Levels 1, 2 or 3 during the three and six months ended June 30, 2024 and 2023.

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

	Other
	Investments
	(in thousands)
Fair value of Level 3 other investment at January 1, 2024	$	285
Investment in affiliate		-
Change in valuation inputs or other assumptions		-
Fair value of Level 3 other investment at June 30, 2024	$	285

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

5. TAXATION

Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and Oxbridge Reinsurance Limited have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and Oxbridge Reinsurance Limited or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.

The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiary is engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.

6. VARIABLE INTEREST ENTITIES

Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective September 1, 2020. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.

The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.

Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes. In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.

In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.

The Company receives an origination and structuring fee in connection with the formation, operation and management of Oxbridge Re NS.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

6. VARIABLE INTEREST ENTITIES (continued)

Notes Payable to Series 2020-1 noteholders

Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2020 and issued $216,000 of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2020-1 and matured on June 1, 2023. Participating notes totaling $98,000 were redeemed during the year ended December 31, 2023 resulting in a balance due of $118,000 at June 30, 2024 and December 31, 2023.

The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the six-months ended June 30, 2024 and 2023 was $0.

SurancePlus Inc.

SurancePlus Inc., a indirect subsidiary of Oxbridge Re Holdings Limited, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purposes of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

On March 27, 2023, the Company and SurancePlus Inc. (“SurancePlus”), issued a press release announcing the commencement of an offering by SurancePlus of DeltaCat tokenized reinsurance securities (the “Tokens”), which represent Series DeltaCat Preferred Shares of SurancePlus (“Preferred Shares”, and together with the Tokens, the “Securities”). Each digital security or token, which will have a purchase price of $10.00 per Token, will represent one Preferred Share of SurancePlus.

The net proceeds from the offer and sale of the Securities were used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes were invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return.

On June 27, 2023, SurancePlus Inc. completed its private placement (the “Private Placement”) of Series DeltaCat Re Preferred Shares represented by DeltaCat Re Tokens (the “Securities”). On June 27, 2023, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 229,766 of the Securities at a purchase price of $10.00 per token for aggregate gross proceeds of $2,297,660. SurancePlus also previously entered into subscription agreements for and sold 15,010 of the Securities between April 5, 2023 and May 18, 2023 for gross proceeds of $150,100, also at a purchase price of $10.00 per token. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 Securities of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 from Oxbridge Re Holdings Limited. Approximately $300,000 and $273,000 of management fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively, The tokens were issued on the Avalanche blockchain. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2023-2024 treaty year.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

6. VARIABLE INTEREST ENTITIES (continued)

On March 18, 2024, Oxbridge Re Holdings Limited (the “Company”) and its indirect wholly owned subsidiary SurancePlus Inc. (“SurancePlus”), a British Virgin Islands Business Company, announced the commencement of an offering by SurancePlus of Participation Shares (the “Securities”) represented by digital tokens to be issued under a 3-year Participation Share Investment Contract (the “PSIC”). The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC. At the offering’s commencement, up to one million (1,000,000) Participation Shares will be issued, represented by digital tokens labelled “EpsilonCat Re”. The quantity of Participation Shares to be issued in subsequent years of 2025, and 2026, shall be disclosed prior to their issuances. At the start of the offering, the Participation Shares will be offered at an initial price of $10.00 per Participation Share.

The net proceeds from the offer and sale of the Participation Shares were used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, an affiliated Cayman Islands licensed reinsurance entity, and the proceeds from the sale of such participating notes were invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the Participation Shares will generally be entitled to proceeds from the payment of the participating notes in the amount of a preferred return equal to the initial Participation Share price, plus 20%, and then 80% of any proceeds in excess of the amount necessary to pay the preferred return.

On July 11, 2024, SurancePlus completed its private placement (the “Private Placement”) of Participation Shares (the “Securities”) represented by digital tokens issued under a 3-year Participation Share Investment Contract (the “PSIC”). On July 11, 2024, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 287,705 of the Participation Shares represented by the digital tokens, EpsilonCat Re at a purchase price of $10.00 per Participation Share for aggregate gross proceeds of $2,878,048 of which approximately $1,469,000 was received from third-party investors and approximately $1,409,000 from Oxbridge Re Holdings Limited. Approximately $312,000 and $299,000 of management fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively, The tokens were issued on the Avalanche blockchain. Ownership of EpsilonCat Re tokenized Participation Shares indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2024-2025 treaty year. The Participation Shares are not shares in SurancePlus have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC.

The Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state or other securities laws. The Securities were sold in a transaction exempt from registration under the Securities Act and were sold only to persons reasonably believed to be accredited investors in the United States under SEC Rule 506(c) under the Securities Act and outside the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act.

The selected unconsolidated historical financial information and other data presented below is derived from SurancePlus’ standalone unaudited financial statements for the three and six months ended June 30, 2024 and the balance sheet data as of June 30, 2024.

SCHEDULE OF FINANCIAL STATEMENTS

Statement of Operations Data:	For Three Months Ended			For Six Months Ended
	June 30, 2024			June 30, 2024
	(Unaudited)			(Unaudited)

Management fee income	$	611		$	612
Underwriting related income		502			991
Net Investment and Other Income		5			5
Total revenue	$	1,118		$	1,608
Expenses	$	(127	)	$	(141	)
Income attributable to tokenholders	$	(457	)	$	(901	)
Net income		534			566

Balance Sheet Data:	At June 30, 2024
	(Unaudited)
	(In thousands)
Total assets	$	3,811
Amounts due to Cat Re Tokenholders*		1,318
Total shareholder’s equity		2,420

*	includes underwriting profit of $78,000 due to Parent.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the six-month periods ending June 30, 2024 and 2023:

SCHEDULE OF LOSS ADJUSTMENT EXPENSE

		At June 30,		At June 30,
		2024		2023
		(in thousands)

Balance, beginning of period	$	-	$	1,073
Incurred related to:
Current period		-		-
Prior period		-		-
Total incurred		-		1,073
Paid related to:
Current period		-		(1,073	)
Prior period		-		-
Total paid		-		(1,073	)
Balance, end of period	$	-	$	-

When losses occur, the reserves for losses and LAE are typically comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company typically suffers limit losses in the event of a Category 3 or above hurricane making landfall in a populated area where the Company has catastrophe risk exposure. For the six-month periods ended June 30, 2024 and 2023, the Company has recorded it’s reserves for losses and LAE based on the contractual maximum loss the Company can suffer under the affected contracts.

The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract-by-contract basis and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.

The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.

There were no losses incurred during the six-month periods ended June 30, 2024 and 2023.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

8. (LOSS) EARNINGS PER SHARE

A summary of the numerator and denominator of the basic and diluted (loss) earnings per share is presented below (dollars in thousands except per share amounts):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023

Numerator:
Net (loss) income	$	(821	)		(85	)	$	(1,726	)		57

Denominator:
Weighted average shares - basic		6,010,561			5,870,234			6,007,868			5,863,973
Weighted average shares - diluted		6,010,561			5,870,234			6,007,868			5,863,973
(Loss) earnings per share - basic	$	(0.14	)		(0.01	)	$	(0.29	)		0.01
(Loss) earnings per share - diluted	$	(0.14	)		(0.01	)	$	(0.29	)		0.01

For the three-month periods ended June 30, 2024 and 2023 and for the six month period ended June 30, 2024 options to purchase 846,250 ordinary shares and 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive due to the net loss during this period.

For the six-month period ended June 30, 2023, options to purchase 846,250 ordinary shares and 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive due to the exercise price of these securities, including unrecognized compensation expense, exceeded the average market price of the Company’s ordinary shares during the period ended June 30, 2023.

GAAP requires the Company to use the two-class method in computing basic (loss) earnings per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common shareholders. These participating securities effect the computation of both basic and diluted (loss) earnings per share during periods of net (loss) income.

9. WARRANTS

There were 8,230,700 warrants outstanding at June 30, 2024 and December 31, 2023. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2029. The Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period. No warrants were exercised during the six- month periods ended June 30, 2024 and 2023.

10. DIVIDENDS

For the period ended June 30, 2024, none of the Company’s retained earnings were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).

Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

11. SHARE-BASED COMPENSATION

The Company currently has outstanding stock-based awards granted under the 2014 Omnibus Incentive Plan (the “2014 Plan”) and the 2021 Omnibus Incentive Plan (the “2021 Plan”) (hereinafter collectively referred to as “the Plans”). Under each of the Plans, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. During the period ended June 30, 2024, the Company granted 136,429 restricted stock to directors, officers and employees under the 2021 Plan. At June 30, 2024, there were 758,926 shares and 11,750 shares available for grant under the 2021 Plan and the 2014 Plan, respectively.

Stock options

Stock options granted and outstanding under the Plan vests quarterly over four years and are exercisable over the contractual term of ten years.

A summary of the stock option activity for the six-month periods ended June 30, 2024 and 2023 is as follows:

SCHEDULE OF STOCK OPTION ACTIVITY

						Weighted-
				Weighted-		Average
	Number			Average		Remaining		Aggregate
	of			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value

Outstanding at January 1, 2023		871,250			4.67		5.6 years		-
Forfeited		(25,000	)	$	6.00
Outstanding at March 31, 2023		846,250		$	4.63		5.5 years		-
Exercisable at March 31, 2023		736,875		$	4.43		5.2 years		-
Outstanding at June 30, 2023		846,250		$	4.63		5.3 years	$	-
Exercisable at June 30, 2023		752,500		$	4.46		5.0 years	$	-
Outstanding at January 1, 2024		846,250		$	4.63		4.8 years	$	-
Outstanding at March 31, 2024		846,250		$	4.63		4.5 years	$	-
Exercisable at March 31, 2024		799,375		$	4.55		4.4 years	$	-
Outstanding at June 30, 2024		846,250		$	4.63		4.3 years	$	-
Exercisable at June 30, 2024		815,000		$	4.58		4.2 years	$	-

Compensation expense recognized for the three-month periods ended June 30, 2024 and 2023 totaled $5,000 and $4,000 and for the six-month periods ended June 30, 2024 and 2023 totaled $15,000 and $10,000.Compensation expense is included in general and administrative expenses. At June 30, 2024 and 2023, there was approximately $10,000 and $30,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of six (6) months.

Restricted Stock Awards

The Company may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of the awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

11. SHARE-BASED COMPENSATION (cont’d)

Restricted stock awards (continued)

During the six-month periods ended June 30, 2024 and 2023, the Company granted 136,427 and 100,647 shares of restricted stock, respectfully to directors and employees under the 2021 Plan. Information with respect to the activity of unvested restricted stock awards during the periods ended June 30, 2024 and 2023 is as follows (share amounts not in thousands):

	Weighted-
	Number of			Weighted-
	Restricted			Average
	Stock			Grant Date
	Awards			Fair Value

Nonvested at January 1, 2024		46,073		$	1.05
Granted		136,427		$	1.05
Vested		(53,074	)	$	1.05
Nonvested at June 30, 2024		129,426

Compensation expense recognized for the three and six-month periods ended June 30, 2024 totaled $29,000 and $91,000, respectively and is included in general and administrative expenses. Compensation expense for the three- and six-month periods ended June 30, 2023 totaled $50,000 and $99,000, respectively. At June 30, 2024, there was approximately $192,000 unrecognized compensation expense related to non-vested restricted stock granted under the Plan, which the Company expects to recognize over a weighted-average period of eight (8) months.

Subsidiary Equity Plan

On March 25, 2024, SurancePlus Holdings Ltd. (“SPH”), a Cayman Islands exempted company and indirectly owned subsidiary of the Company, adopted and approved the SurancePlus Holdings Ltd. 2024 Equity Incentive Plan (the “SPH Equity Incentive Plan”), which authorizes SPH to grant restricted SPH shares, restricted share units, incentive share options, non-qualified share options, and other share-based awards to officers, directors, employees, and consultants of SPH in order to incentivize and align their interests with the interests of SPH and other shareholders in SPH. The SPH Equity Incentive Plan authorizes the grant of incentive awards with respect to up to 750,000 shares of SPH Ordinary Shares, subject to customary adjustments. The SPH Equity Incentive Plan is administered by the board of directors of SPH (the “SPH Board”) or any committee of SPH directors appointed by the SPH Board. The SPH Equity Incentive Plan contains various other customary terms and conditions, and unless terminated earlier, the SPH Equity Incentive Plan will terminate on the 10th anniversary of the effective date of the SPH Equity Incentive Plan. The Company, as the initial sole shareholder of SPH, also approved the SPH Equity Incentive Plan on March 25, 2024, by action of the Company’s board of directors.

On March 25, 2024, the SPH Board granted to SPH employees an aggregate of 200,000 SPH Ordinary Shares pursuant to a form of Restricted Share Award Agreement (the “SPH Restricted Share Agreement”) that vest ratably over a period of 1 to 2 years. The SPH Board also granted options to purchase 548,100 SPH Ordinary Shares pursuant to a form of Option Award Agreement (the “SPH Option Award Agreement”) which vest in quarterly increments over a period of 4 years and has an exercise price of $15 per share. The restricted shares and option grants are subject to the holder of the restricted shares and options remaining continuously employed by the Company or its subsidiaries through and as of the applicable vesting date. Upon a change of control of SPH (as defined in the SPH Equity Incentive Plan), any unvested restricted shares and options shall immediately vest.

12. NET WORTH FOR REGULATORY PURPOSES

The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.

At June 30, 2024, the Oxbridge Reinsurance Limited’s net worth of $7,000 exceeded the minimum and prescribed capital requirement. For the six-month periods ended June 30, 2024 and 2023, Oxbridge Reinsurance Limited’s net loss was approximately $2.1 million and $420,000, respectively.

At June 30, 2024, the Oxbridge Re NS’ net worth of $303,000 exceeded the minimum and prescribed capital requirement. For the three and six-month periods ended June 30, 2024 and 2023 Oxbridge Re NS’ net income was approximately $79,000 and $NIL, respectively.

The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries’ GAAP capital, surplus and net (loss) income, and its statutory capital, surplus and net (loss) income as of June 30, 2024 or for the period then ended.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES)

Fair values

With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities as disclosed in Note 4 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, accrued interest and dividends receivable, premiums receivable and other assets, notes payable and accounts payable and other liabilities, approximate their fair values due to their short-term nature.

Concentration of underwriting risk

A substantial portion of the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities; accordingly, the Company’s underwriting risks are not significantly diversified.

Concentrations of Credit and Counterparty Risk

The Company markets retrocessional and reinsurance policies worldwide through its brokers. Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company. For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, in the Company. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.

The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements. The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.

The Company mitigates its concentrations of credit and counterparty risk by using reputable and several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty.

Market risk

Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

14. LEASES

Operating lease right-of-use assets and operating lease liabilities are disclosed as line in the consolidated balance sheets. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.

The Company has two operating lease obligations namely for the Company’s office facilities located at Suite 201, 42 Edward Street Grand Cayman, Cayman Islands and residential space at Turnberry Villas in Grand Cayman, Cayman Islands. The office lease has a remaining lease term of approximately thirty-two (32) months and includes an option to extend the lease. Under the terms of the lease, the Company also has the right to terminate the lease after thirty-six (36) months upon giving appropriate notice in writing to the Lessor. The residential lease has a remaining lease term of approximately six (6) months.

The components of lease expense and other lease information as of and during the six-month periods ended June 30, 2024 and 2023 are as follows:

SCHEDULE OF OPERATING LEASE COST


	For the Six- Month Period		For the Six- Month Period
(in thousands)	Ended June 30, 2024		Ended June 30, 2023
Operating Lease Cost ⁽¹⁾	$	53	$	50

Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	53	$	50

(1)	Includes short-term leases

SCHEDULE OF OPERATING LEASE OBLIGATIONS

(in thousands)	At June 30, 2024			At December 31, 2023
Operating lease right-of-use assets	$	124		$	9

Operating lease liabilities	$	124		$	9

Weighted-average remaining lease term - operating leases		2.13 years			0.39 years

Weighted-average discount rate - operating leases		9.25	%		7.13%

Future minimum lease payments under non-cancellable leases as of June 30, 2024 and December 31, 2023, reconciled to our discounted operating lease liability presented on the consolidated balance sheet are as follows:

(in thousands)	At June 30, 2024			At December 31, 2023
Remainder of 2024	$	53		$	9
2025		39			-
2026		39			-
Thereafter		6			-
Total future minimum lease payments	$	137		$	9

Less imputed interest		(13	)		-
Total operating lease liability	$	124		$	9

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

15. RELATED PARTY TRANSACTIONS

Epsilon Re Tokens

During the six-month period ended June 30, 2024, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, entered into subscription agreement to purchase a total of 9,245 Series Epsilon Cat Re tokens at a purchase price of $10.00 per token for aggregate gross proceeds of $92,447. Ownership of EpsilonCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re NS for the 2024-2025 treaty year.

TypTap Insurance Company (“TypTap”) Contract

During the three-month and six-month periods ended June 30, 2024 the Company entered into a reinsurance agreement with TypTap, an insurance subsidiary of HCI Group, Inc., which is a related entity through common directorship. At June 30, 2024, included within premium receivable, deferred acquisition costs and unearned premiums on the condensed consolidated balance sheets are amounts equal to $893,000, $101,000 and $920,000 respectively, relating to the reinsurance agreement with TypTap. During the three-month and six-month periods ended June 30, 2024, included within assumed premiums, change in unearned premium reserve and policy acquisition costs and underwriting expenses on the consolidated statements of income are amounts equal to $1,004,000 ($462,000) and $59,000, respectively.

Bridge Loan with Affiliate

On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $500,000 of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and matured on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.

The Company invested the sum of $100,000 in the Notes and was previously recorded as “Loan Receivable” on the consolidated balance sheets at cost. On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company received an aggregate of $141,000 upon the redemption of the Notes.

16. SUBSEQUENT EVENTS

We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements.

On July 11, 2024, SurancePlus Inc. (“SurancePlus”), an indirect wholly owned subsidiary of Oxbridge Re Holdings Limited (“Oxbridge”), completed its private placement (the “Private Placement”) of Participation Shares (the “Securities”) represented by digital tokens issued under a 3-year Participation Share Investment Contract (the “PSIC”). On July 11, 2024, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 287,705 of the Participation Shares represented by the digital tokens, EpsilonCat Re at a purchase price of $10.00 per Participation Share for aggregate gross proceeds of $2,878,048 of which approximately $1,469,000 was received from third-party investors and approximately $1,409,000 from Oxbridge Re Holdings Limited. Approximately $312,000 and $299,000 of management fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively, The tokens were issued on the Avalanche blockchain. Ownership of EpsilonCat Re tokenized Participation Shares indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2024-2025 treaty year. The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC.

The Securities were issued pursuant to the exemptions from registration contained in Rule 506(c) of Regulation D and Regulation S of the Securities Act of 1933, as amended (the “Securities Act”). SurancePlus relied, in part, upon representations made in the subscription agreements by each subscriber that the subscriber was an accredited investor as defined in Regulation D under the Securities Act or was not a U.S. Person as defined under Rule 902 of Regulation S. The issuance involved general solicitation in connection with the offering as permitted by Rule 506(c) of Regulation D. No underwriting discounts or commissions were or will be paid with respect to such sales.

ATM Facility

Subsequent to June 30, 2024, and through the date of issuance of these financial statements, we sold an additional 131,795 ordinary shares under the ATM program for gross proceeds of $385,365, at an average price $2.92 per ordinary share. After deducting commissions related to the ATM offering of $11,561, the net proceeds we received from the transactions were $373,804 We plan to use the proceeds for working capital and general corporate purposes.

Warrant Conversion

On July 29, 2024, the Company’s 3,094,999 warrants were converted into 945,211 of Jet.AI’s common stock in accordance with Jet.AI’s Tender Offer Statement (as amended) as filed with the Securities and Exchange Commission on July 23, 2024.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS

Certain statements in this Quarterly Report on Form 10-Q, including in this Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 26, 2024. We undertake no obligation to publicly update or revise any forward -looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward -looking statements which speak only to the dates on which they were made.

GENERAL

The following is a discussion and analysis of our results of operations for the three and six-month periods ended June 30, 2024 and 2023 and our financial condition as of June 30, 2024 and December 31, 2023. The following discussion should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 26, 2024. References to “we,” “us,” “our,” “our company,” or “the Company” refer to Oxbridge Re Holdings Limited and its wholly-owned subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS, unless the context dictates otherwise.

Overview and Trends

We are a Cayman Islands specialty property and casualty reinsurer that provides reinsurance solutions through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS. We focus on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. We specialize in underwriting medium frequency, high severity risks, where we believe sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. Oxbridge Re NS functions as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS issues participating notes to third party investors, the proceeds of which are utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations.

In addition to our historical reinsurance business operations, in 2023, our new subsidiary SurancePlus developing, offering, and selling a tokenized reinsurance security representing fractionalized interests in reinsurance contracts, with each token representing an interest in participating notes issued by Oxbridge Re NS. These efforts culminated in the development, launch, and issuance of our first tokenized reinsurance security, the DeltaCat Re Token, which we believe is the first “on-chain” reinsurance security of its kind to be developed by a subsidiary of a public company. Following the issuance of the DeltaCat Re Token, we intend to develop, launch, and issue additional series of tokenized reinsurance securities representing fractional interests in reinsurance contracts, and we are also using our tokenization experience and activities as a foundation for developing Web3-focused business offerings and products relating to the tokenization of other real-world assets (RWAs), including RWAs held or being acquired by third parties. Our tokenization business will be conducted through SurancePlus and through other subsidiaries of our wholly owned subsidiary, SurancePlus Holdings Ltd. (“SurancePlus Holdings”), [a Cayman Islands exempted company] that we have organized to serve as a holding company for subsidiaries that will operate our developing Web3-focused business operations.

In our historical reinsurance business operations, we underwrite reinsurance contracts on a selective and opportunistic basis as opportunities arise based on our goal of achieving favorable long-term returns on equity for our shareholders. Our goal is to achieve long-term growth in book value per share by writing business that generates attractive underwriting profits relative to the risk we bear. Additionally, we intend to complement our underwriting profits with investment profits on an opportunistic basis. Our underwriting business focus is on fully collateralized reinsurance contracts for property catastrophes, primarily in the Gulf Coast region of the United States. Within that market and risk category, we attempt to select the most economically attractive opportunities across a variety of property and casualty insurers. As we attempt to grow our capital base, we expect that we will consider further growth opportunities in other geographic areas and risk categories.

Our level of profitability is primarily determined by how adequately our premiums assumed and investment income cover our costs and expenses, which consist primarily of acquisition costs and other underwriting expenses, claim payments and general and administrative expenses. One factor leading to variation in our operational results is the timing and magnitude of any follow-on offerings we undertake (if any), as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions, judicial trends, and fluctuations in interest rates and other changes in the investment environment.

Because we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

Compared to most of our competitors, we are small and have low overhead expenses. We believe that our expense efficiency, agility and existing relationships support our competitive position and allows us to profitably participate in lines of business that fit within our strategy. Over time we expect our expense advantage to erode as the industry acts to reduce frictional costs.

Recent Developments

Formation of SurancePlus

SurancePlus, an indirect wholly-owned subsidiary of the Company, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purpose of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

On March 27, 2023, we, through SurancePlus, issued a press release announcing the commencement of an offering by SurancePlus of up to $5.0 million of DeltaCat Re Tokens with a purchase price of $10.00 per DeltaCat Re Token and representing one share of Series DeltaCat Re Preferred Shares per DeltaCat Re Token (the “Private Placement”).

On June 27, 2023, SurancePlus completed the Private Placement. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 DeltaCat Re Tokens, of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 was received from Oxbridge Re Holdings Limited.

On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of British Virgin Islands law.

On March 18, 2024, Oxbridge Re Holdings Limited (the “Company”) and its indirect wholly owned subsidiary SurancePlus Inc. (“SurancePlus”), a British Virgin Islands Business Company, announced the commencement of an offering by SurancePlus of Participation Shares (the “Securities”) represented by digital tokens to be issued under a 3-year Participation Share Investment Contract (the “PSIC”). The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC. At the offering’s commencement, up to one million (1,000,000) Participation Shares were issued, represented by digital tokens labelled “EpsilonCat Re”. The quantity of Participation Shares to be issued in subsequent years of 2025, and 2026, shall be disclosed prior to their issuances. At the start of the offering, the Participation Shares were offered at an initial price of $10.00 per Participation Share.

The net proceeds from the offer and sale of the Participation Shares were used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, an affiliated Cayman Islands licensed reinsurance entity, and the proceeds from the sale of such participating notes were invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the Participation Shares are generally be entitled to proceeds from the payment of the participating notes in the amount of a preferred return equal to the initial Participation Share price, plus 20%, and then 80% of any proceeds in excess of the amount necessary to pay the preferred return.

On July 11, 2024, SurancePlus Inc. (“SurancePlus”), an indirect wholly owned subsidiary of Oxbridge Re Holdings Limited (“Oxbridge”), completed its private placement (the “Private Placement”) of Participation Shares (the “Securities”) represented by digital tokens issued under a 3-year Participation Share Investment Contract (the “PSIC”). On July 11, 2024, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 287,705 of the Participation Shares represented by the digital tokens, EpsilonCat Re at a purchase price of $10.00 per Participation Share for aggregate gross proceeds of $2,878,048 which approximately $1,469,000 was received from third-party investors and approximately $1,409,000 from Oxbridge Re Holdings Limited. Approximately $312,000 and $299,000 of management fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively, The tokens were issued on the Avalanche blockchain. Ownership of EpsilonCat Re tokenized Participation Shares indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2024-2025 treaty year. The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC.

Oxbridge Acquisition Corp.

On February 28, 2023, the Company announced in a press release that Oxbridge Acquisition filed a Current Report on Form 8-K with the Securities and Exchange Commission in connection with Oxbridge Acquisition’s business combination with Jet Token Inc. (“Jet”), a Delaware based company. Upon the closing of the transaction, the combined company will be named Jet.AI Inc. Jet offers fractional aircraft ownership, jet card, aircraft brokerage and charter service through its fleet of private aircraft and those of Jet’s Argus Platinum operating partner. Jet’s charter app enables travelers to look, book and fly. The funding and capital markets access from this transaction is expected to enable Jet to continue its growth strategy of AI software development and fleet expansion. The business combination was completed on August 10, 2023.

The Company’s wholly-owned licensed reinsurance subsidiary, Oxbridge Reinsurance Limited (“Oxbridge Reinsurance”), is the lead investor in Oxbridge Acquisition’s sponsor and at June 30, 2024, held the equivalent of 1,423,827 of Jet.AI Inc’s common stock (NASDAQ: JTAI) and 3,094,999 of Jet.AI Inc’s warrants (NASDAQ: JTAIW). On July 29, 2024, the Company’s 3,094,999 warrants were converted into 945,211 of Jet.AI’s common stock in accordance with Jet.AI’s Tender Offer Statement (as amended) as filed with the Securities and Exchange Commission on July 23, 2024.

Bridge Loan with Affiliate

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and mature on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

ATM Facility

On September 30, 2022, the Company entered into an Equity Distribution Agreement (the “Offering Agreement”) with Maxim Group LLC, as sales agent (the “Sales Agent”), pursuant to which the Company could offer and sell, from time to time, through the Sales Agent up to $6,300,000 of the Company’s ordinary shares, $0.001 par value (“Ordinary Shares”). The expiration date of the Offering Agreement is the earlier of (i) the issuance and sale of the Ordinary Shares having an aggregate offering price equal to $6,300,000, or (ii) the termination of the Offering Agreement by either the Sales Agent or the Company, in each such party’s sole discretion, upon the provision of thirty (30) days’ written notice. The Company will pay the Sales Agent a commission equal to 3.0% of the gross proceeds of the Ordinary Shares sold by the Sales Agent pursuant to the Offering Agreement.

Sales of the Ordinary Shares under the Offering Agreement, if any, may be made in transactions that are deemed to be “at-the-market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, including without limitation sales made directly on or through the Nasdaq Capital Market or any other existing trading market for the Ordinary Shares. The Sales Agent will use commercially reasonable efforts consistent with its normal trading and sales practices to sell the Ordinary Shares from time to time, based upon instructions from the Company (including any price, time or amount limits the Company may impose). The Company is not obligated to make any sales under the Offering Agreement.

The Ordinary Shares were registered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-262590) (the “Registration Statement”), and offerings of the Ordinary Shares will be made only by means of a prospectus supplement.

As of June 30, 2024, we have sold 29,918 shares of our common stock under the ATM program for gross proceeds of $77,000. After deducting commissions related to the ATM offering of $2,000, the net proceeds we received from the transactions were $75,000. The proceeds from the ATM sales are being used for general corporate purposes.

PRINCIPAL REVENUE AND EXPENSE ITEMS

Revenues

We derive our most significant revenues from three principal sources:

	●	premiums assumed from reinsurance on property and casualty business;
	●	income from investments and unrealized (loss) gain on other investments;
	●	income from SurancePlus management fees.

Premiums Assumed

Premiums assumed include all premiums received by a reinsurance company during a specified accounting period, even if the policy provides coverage beyond the end of the period. Premiums are earned over the term of the related policies. At the end of each accounting period, the portion of the premiums that are not yet earned are included in the unearned premiums reserve and are realized as revenue in subsequent periods over the remaining term of the policy. Our policies typically have a term of twelve months. Thus, for example, for a policy that is written on July 1, 2024, typically one-half of the premiums will be earned in 2024 and the other half will be earned during 2025. However, in the event of limit losses on our policies, premium recognition will be accelerated to match losses incurred in the period, when there is no possibility of any future treaty-year losses under the contracts.

Premiums from reinsurance on property and casualty business assumed are directly related to the number, type and pricing of contracts we write.

Premiums assumed are recorded net of change in loss experience refund, which consists of changes in amounts due to the cedants under two of our reinsurance contracts. These contracts contain retrospective provisions that adjust premiums in the event losses are minimal or zero. We recognize a liability pro-rata over the period in which the absence of loss experience obligates us to refund premiums under the contracts, and we will derecognize such liability in the period in which a loss experience arises. The change in loss experience refund is negatively correlated to loss and loss adjustment expenses described below.

Investment Income

Income from our investments is primarily comprised of net realized and unrealized (losses) gains interest income and dividends on investment securities. Such income is primarily from the Company’s investments, which includes other investments in Jet.AI and investments held in trust accounts that collateralize the reinsurance policies that we write. The investment parameters for trust accounts are generally be established by the cedant for the relevant policy.

Incentive, Technology, Origination and Management Fee Income

During the six-month period ended June 30, 2024, the Company’s subsidiary, SurancePlus Inc., entered into subscriptions agreements for the sale of its participation Shares represented by the digital, representing fractionalized interest in reinsurance contracts underwritten by Oxbridge Re NS. The tokens were issued on the Avalanche blockchain.

SurancePlus receives an incentive and management fee to cover costs associated with origination, structuring and the blockchain technology related to the tokens. These fees are included in SurancePlus management fee line item in the consolidated statements of operations.

Expenses

Our expenses consist primarily of the following:

	●	losses and loss adjustment expenses;

	●	policy acquisition costs and underwriting expenses; and

	●	general and administrative expenses.

Loss and Loss Adjustment Expenses

Loss and loss adjustment expenses are a function of the amount and type of reinsurance contracts we write and of the loss experience of the underlying coverage. As described below, loss and loss adjustment expenses are based on the claims reported by our Company’s ceding insurers, and may include an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Depending on the nature of the contract, loss and loss adjustment expenses may be paid over a period of years.

Policy Acquisition Costs and Underwriting Expenses

Policy acquisition costs and underwriting expenses consist primarily of brokerage fees, ceding commissions, premium taxes and other direct expenses that relate to our writing of reinsurance contracts. We amortize deferred acquisition costs over the related contract term.

General and Administrative Expenses

General and administrative expenses consist of salaries and benefits and related costs, including costs associated with our professional fees, rent and other general operating expenses consistent with operating as a public company.

RESULTS OF OPERATIONS

The following is our consolidated statement of operations and performance ratios for the three and six-month periods ended June 30, 2024 and 2023 (dollars in thousands, except per share amounts):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023

Revenue
Assumed premiums	$	2,379		$	2,196		$	2,379		$	2,196
Change in unearned premiums reserve		(1,815	)		(2,013	)		(1,266	)		(2,013	)

Net premiums earned		564			183			1,113			183
SurancePlus management fee income		312			300			312			300
Net investment and other income		65			79			126			168
Interest and gain on redemption of loan receivable		-			-			41			-
Unrealized (loss) gain on other investments		(825	)		124			(1,513	)		505
Change in fair value of equity securities		(72	)		5			(160	)		81

Total revenue		44			691			(81	)		1,237

Expenses
Policy acquisition costs and underwriting expenses		62			20			122			20
General and administrative expenses		566			677			1,054			1,081

Total expenses		628			697			1,176			1,101

(Loss) income before income attributable to noteholders and tokenholders		(584	)		(6	)		(1,257	)		136

Income attributable to noteholders and tokenholders		(237	)		(79	)		(469	)		(79	)

Net (loss) income	$	(821	)	$	(85	)	$	(1,726	)	$	57

(Loss) earnings per share
Basic and Diluted	$	(0.14	)	$	(0.01	)	$	(0.29	)	$	0.01

Weighted-average shares outstanding
Basic and Diluted		6,010,561			5,870,234			6,007,868			5,863,973

Performance ratios to net premiums earned:
Loss ratio	0.0	%	0.0	%	0.0	%	0.0	%
Acquisition cost ratio	11.0	%	10.9	%	11.0	%	10.9	%
Expense ratio	111.3	%	380.9	%	105.7	%	601.6	%
Combined ratio	111.3	%	380.9	%	105.7	%	601.6	%

General. Net loss for the quarter ended June 30, 2024 was $821,000, or ($0.14) basic and diluted earnings per share compared to a net loss of $85,000, or ($0.01) basic and diluted loss per share, for the quarter ended June 30, 2023. The increase in net loss is primarily due to the negative change in the fair value of equity securities and investments during the quarter ended June 30, 2024 when compared with the prior period.

Net loss for the six months ended June 30, 2024 was $1.73 million or $0.29 per basic or diluted earnings per share compared to a net income of $57,000, or $0.01 per basic and diluted income per share, for the six months ended June 2023. The increase in net loss was the result of the negative change in the fair value of equity securities and investments which outweighed the revenue driven by increase in SurancePlus management fee income, during the six months ended June 30, 2024 when compared with the prior period.

Premium Income. Net premiums earned typically reflects the pro rata inclusion into income of premiums assumed over the life of the reinsurance contracts.

Net premiums earned for the quarter ended June 30, 2024 increased to $564,000 from $183,000 for the quarter ended June 30, 2023. This increase is attributed to the prior period recognizing only one month of premiums due to the acceleration of premiums on contracts in force during the quarter ended June 30, 2023. In contrast, the current year accounted for a full quarter of premiums.

Net premiums earned for the six months ended June 30, 2024, increased to $1.1 million from $183,000 for the same period in 2023. This increase is primarily due to the prior year recognizing only one month of premiums because of premium acceleration on the reinsurance contracts in force. In contrast, the six months ended June 30, 2024, recognized a full six months of premiums.

Losses Incurred. There were no losses incurred during the six-month periods ending June 30, 2024 and 2023.

Policy Acquisition Costs and Underwriting Expenses. Acquisition costs represent the amortization of the brokerage fees and federal excise taxes incurred on reinsurance contracts placed. Policy acquisition costs and underwriting expenses for the quarter ended June 30, 2024 increased to $62,000 from $20,000 for the quarter ended June 30, 2023.

Policy acquisition costs and underwriting expenses for the six months ended June 30, 2024 increased to $122,000 from $20,000 for the six-months ended June 30, 2023.

The increases are primarily due to the prior periods recognizing only one month of policy acquisition costs because of premium and acquisition costs acceleration on the reinsurance contracts in force. In contrast, the quarter and six months ended June 30, 2024, recognized a full three and six months of policy acquisition costs, respectively.

General and Administrative Expenses. General and administrative expenses for the quarter ended June 30, 2024 decreased to $ 566,000, from $677,000 for the quarter ended June 30, 2023. The decrease is due to the decrease in offering costs associated with SurancePlus being recognized during the three-month period ending June 30, 2024 when compared with the same period last year.

General and administrative expenses for the six months ended June 30, 2024 decreased to $1.05 million, from $1.1 million, for the quarter ended June 30, 2023. The decrease is due to expense fluctuations along with the decrease in offering costs associated with SurancePlus being recognized during the six-month period ending June 30, 2024 when compared to the prior period.

MEASUREMENT OF RESULTS

We use various measures to analyze the growth and profitability of business operations. For our reinsurance business, we measure growth in terms of premiums assumed and we measure underwriting profitability by examining our loss, underwriting expense and combined ratios. We analyze and measure profitability in terms of net income and return on average equity.

Premiums Assumed. We use gross premiums assumed to measure our sales of reinsurance products. Gross premiums assumed also correlate to our ability to generate net premiums earned.

Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio remained consistent at 0% for the quarter end June 30, 2024 compared with the quarter ended June 30, 2023.

Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business.

The acquisition cost ratio increased marginally to 11.0% for the six-month period ended June 30, 2024, from 10.9% for the six-month period ended June 30, 2023. The increase is primarily to premiums being earned during the period ending June 30, 2024, when compared with the prior period.

Expense Ratio. The expense ratio is the ratio of policy acquisition costs, other underwriting expenses and general and administrative expenses to net premiums earned. We use the expense ratio to measure our operating performance. The expense ratio decreased from 601.6% for the six-month period ended June 30, 2023 to 105.7% for the six-month period ended June 30, 2024. The improvement is due to the higher levels of premium earned during the six-month period ended June 30, 2024, when compared with the prior period.

Combined Ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. The combined ratio decreased from 601.6% for the six-month period ended June 30, 2023 to 105.7% for the six-month period ended June 30, 2024. The improvement is due to the higher levels of premium earned during the six-month period ended June 30, 2024, when compared with the prior period.

FINANCIAL CONDITION –JUNE 30, 2024 COMPARED TO DECEMBER 31, 2023

Cash and Cash Equivalents and Restricted Cash and Cash Equivalents. As of June 30, 2024, our restricted cash and cash equivalents increased by $240,000, or 6.40%, to $3.99 million, from $3.75 million as of December 31, 2023. The increase is the result of premium deposits made during the six months ended June 30, 2024.

Investments. As of June 30, 2024, our total investments decreased by $467,000 or 69% to $213,000, from $680,000 as of December 31, 2023. The decrease is primarily a result of the sale of two of the equity securities and the decrease in value of the equity securities during the six-month period ended June 30, 2024.

Other investments. As of June, 30, 2024, our other investments decreased $1.5 million to $965,000 from $2.48 million at December 31, 2023. The decrease is due to fair value changes of our investment in Jet.AI in which the Company has an equity investment measured at fair value.

Notes Payable to Noteholders. As of June 30, 2024, our notes payable remained stable at $118,000.

Other liabilities – Cat Re Tokenholders. As of June 30, 2024, amounts due to Cat Re tokenholders decreased by $284,000 from $1.52 million at December 31, 2023. The decrease is due to returns made to investors who invested in Delta Cat Re tokens outweighing the proceeds from third-party investors purchasing the Epsilon Cat Re participation shares represented by digital tokens (net of management fees), plus one month underwriting-relating income that is attributable to third-party tokenholders.

Unearned Premium Reserve. As of June 30, 2024, our unearned premium reserve increased by $1.3 million to $2,181,000 from $915,000 at December 31, 2023. The increase is due to reinsurance contracts placed for the 2024 2025 treaty year.

LIQUIDITY AND CAPITAL RESOURCES

General

We are organized as a holding company and provide administrative and management services to our subsidiaries. Our operations are conducted through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS and our web3 focused subsidiary SurancePlus Inc. which underwrites risks associated with our property and casualty reinsurance programs as well as the tokenization of RWAs such as Reinsurance contracts. We have minimal continuing cash needs at the holding company level, with such needs principally being related to the payment of administrative expenses and shareholder dividends. There are restrictions on Oxbridge Reinsurance Limited’s and Oxbridge Re NS’ ability to pay dividends which are described in more detail below.

Sources and Uses of Funds

Our sources of funds primarily consist of premium receipts (net of brokerage fees and federal excise taxes, where applicable) and investment income, including interest, dividends and realized gains. We use cash to pay losses and loss adjustment expenses, other underwriting expenses, dividends, and general and administrative expenses. Substantially all our surplus funds, net of funds required for cash liquidity purposes, are invested in accordance with our business plan and investment guidelines. Our investment portfolio, except for our investment in Jet.AI, is primarily comprised of cash and highly liquid securities, which can be liquidated, if necessary, to meet current liabilities. We believe that we have sufficient flexibility to liquidate any securities that we own to generate liquidity.

As of June 30, 2024, we believe we had sufficient cash flows from operations to meet our liquidity requirements. We expect that our operational needs for liquidity will be met by cash, investment income and funds generated from underwriting activities. We have no plans to issue debt, and we expect to fund our operations for the foreseeable future from operating cash flows, as well as from potential future equity offerings. However, we cannot provide assurances that in the future we will not incur indebtedness to implement our business strategy, pay claims or make acquisitions.

Although Oxbridge Re Holdings Limited is not subject to any significant legal prohibitions on the payment of dividends, its subsidiaries Oxbridge Reinsurance Limited and Oxbridge Re NS are subject to Cayman Islands regulatory constraints that affect its ability to pay dividends to us and include a minimum net worth requirement. Currently, the minimum net worth requirement for each subsidiary is $500. As of June 30, 2024, each subsidiary exceeded the minimum required. By law, each subsidiary is restricted from paying a dividend if such a dividend would cause its net worth to drop to less than the required minimum.

Cash Flows

Our cash flows from operating, investing, and financing activities for the six-month periods ended June 30, 2024 and 2023 are summarized below.

Cash Flows for the Six months ended June 30, 2024 (in thousands)

Net cash used in operating activities for the six months ended June 30, 2024 totaled $1,752, which consisted primarily of cash received net written premiums less cash disbursed for operating expenses. Net cash provided by investing activities of $448 which was due to the repayment of the note receivable by Jet.AI and the proceeds from the sale of two of our equity securities. Net cash provided by financing activities was $1,544 which consisted primarily of net proceeds from Epsilon Cat Re participation shares represented by digital tokens offset by the payments made to DeltaCat Re tokenholders.

Cash Flows for the Six months ended June 30, 2023 (in thousands)

Net cash used in operating activities for the six-months ended June 30, 2023 totaled $1,614, which consisted primarily of cash received net written premiums less cash disbursed for operating expenses. Net cash used in investing activities of $5 Net cash provided by financing activities was $1,180 which consisted primarily of net proceeds from Delta Cat Re Tokens offset by the payment made to noteholders.

OFF-BALANCE SHEET ARRANGEMENTS

As of June 30, 2024, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

Exposure to Catastrophes

As with other reinsurers, our operating results and financial condition could be adversely affected by volatile and unpredictable natural and man-made disasters, such as hurricanes, windstorms, earthquakes, floods, fires, riots and explosions. Although we attempt to limit our exposure to levels, we believe are acceptable, it is possible that an actual catastrophic event or multiple catastrophic events could have a material adverse effect on our financial condition, results of operations and cash flows. As described under “CRITICAL ACCOUNTING POLICIES—Reserves for Losses and Loss Adjustment Expenses” below, under accounting principles generally accepted in the United States of America (‘‘GAAP’’), we are not permitted to establish loss reserves with respect to losses that may be incurred under reinsurance contracts until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date may be established, with no provision for a contingency reserve to account for expected future losses.

CRITICAL ACCOUNTING POLICIES

We are required to make estimates and assumptions in certain circumstances that affect amounts reported in our consolidated financial statements and related footnotes. We evaluate these estimates and assumptions on an on-going basis based on historical developments, market conditions, industry trends and other information that we believe to be reasonable under the circumstances. These accounting policies pertain to fair value measurements, particular with respect to our beneficial interest in Jet.AI., premium revenues and risk transfer, reserve for loss and loss adjustment expenses, and deferred acquisition costs.

The three levels of the fair value hierarchy under GAAP are as follows:

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active;

and

Level 3 Inputs that are unobservable.

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. The fair value of our indirect investment in Jet.AI is based on the last traded price in an actively traded market. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians and management consider observable data to be market data, which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument, as well as the marketability of the instrument and the risk of forfeiture of such instrument.

Premium Revenue and Risk Transfer. We record premiums revenue as earned pro-rata over the terms of the reinsurance agreements and the unearned portion at the balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

We account for reinsurance contracts in accordance with ASC 944, ‘‘Financial Services – Insurance.” Assessing whether or not a reinsurance contract meets the conditions for risk transfer requires judgment. The determination of risk transfer is critical to reporting premiums written. If we determine that a reinsurance contract does not transfer sufficient risk, we must account for the contract as a deposit liability.

Reserves for Losses and Loss Adjustment Expenses. We determine our reserves for losses and loss adjustment expenses on the basis of the claims reported by our ceding insurers and for losses IBNR, we use the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses.

We believe that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of income in the period in which they are determined.

Under GAAP, we are not permitted to establish loss reserves until the occurrence of an actual loss event. As a result, only loss reserves applicable to losses incurred up to the reporting date may be recorded, with no allowance for the provision of a contingency reserve to account for expected future losses. Losses arising from future events, which could be substantial, are estimated and recognized at the time the loss is incurred.

As at June 30, 2024 we had no reserves for loss and loss adjustment expenses due to no significant events occurring during the year and no reported claims on contract in force. See Note 7 to the consolidated financial statements.

Our reserving methodology does not lend itself well to a statistical calculation of a range of estimates surrounding the best point estimate of our reserve for loss and loss adjustment expense. Due to the low frequency and high severity nature of claims within much of our business, our reserving methodology principally involves arriving at a specific point estimate for the ultimate expected loss on a contract-by-contract basis, and our aggregate loss reserves are the sum of the individual loss reserves established.

Deferred Acquisition Costs. We defer certain expenses that are directly related to and vary with producing reinsurance business, including brokerage fees on gross premiums assumed, premium taxes and certain other costs related to the acquisition of reinsurance contracts. These costs are capitalized and the resulting asset, deferred acquisition costs, is amortized and charged to expense in future periods as premiums assumed are earned. The method followed in computing deferred acquisition costs limits the amount of such deferral to its estimated realizable value. The ultimate recoverability of deferred acquisition costs is dependent on the continued profitability of our reinsurance underwriting. If our underwriting ceases to be profitable, we may have to write off a portion of our deferred acquisition costs, resulting in a further charge to income in the period in which the underwriting losses are recognized.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company as defined by Rule 229.10(f)(1) of the Exchange Act, we are not required to provide the information under this item.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

We are not currently involved in any litigation or arbitration. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will be subject to litigation and arbitration in the ordinary course of business.

Item 1A.

Risk Factors

There have been no material changes to our risk factors during the six months ended June 30, 2024. However, we draw attention to the below risk factors relating to our investment in Jet.AI Inc. that can have a material impact on our earnings and shareholders’ equity in the near term.

Our use of fair value accounting of our significant investment in Jet.AI Inc. could result in income statement volatility, which in turn, could cause significant market price and trading volume fluctuations for our securities.

Our significant beneficial interests in Jet.AI Inc.’s common stock and public warrants are recorded at fair value with changes in fair value being recorded in the consolidated statement of operations during the period of change. Additionally, the fair value of the investment must be remeasured quarterly. Because of this, and due to significance of our investment in Jet.AI relative to our total assets, our earnings may experience greater volatility in the future as a decline in the fair value of our investment in Jet.AI Inc. could significantly reduce both our earnings and shareholders’ equity, which in turn, could cause significant market price and trading volume fluctuations for our securities.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

(a)

Sales of Unregistered Securities

None.

(b)

Repurchases of Equity Securities

None.

(c)

Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

The following exhibits are filed herewith:

Exhibit No.		Document

31.1		Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.

31.2		Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.

32		Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.

101		The following materials from Oxbridge Re Holdings Limited’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 are filed herewith, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Changes in Shareholders’ Equity and (vi) the Notes to Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	OXBRIDGE RE HOLDINGS LIMITED

Date: August 8, 2024	By:	/s/ JAY MADHU
		Jay Madhu
		Chief Executive Officer and President
		(Principal Executive Officer)

Date: August 8, 2024	By:	/s/ WRENDON TIMOTHY
		Wrendon Timothy
		Chief Financial Officer and Secretary
		(Principal Financial Officer and Principal Accounting Officer)

Exhibit 31.1

Certifications of the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Jay Madhu, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Oxbridge Re Holdings Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2024

	By:	/s/ JAY MADHU
		Jay Madhu
		Chief Executive Officer and President
		(Principal Executive Officer)

Exhibit 31.2

Certifications of the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and

Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Wrendon Timothy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Oxbridge Re Holdings Limited;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2024

	By:	/s/ WRENDON TIMOTHY
		Wrendon Timothy
		Chief Financial Officer and Secretary
		(Principal Financial Officer and Principal Accounting Officer)

Exhibit 32

Written Statement of the Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. §1350

Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of Oxbridge Re Holdings Limited (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JAY MADHU
Jay Madhu
Chief Executive Officer and President
(Principal Executive Officer)

/s/ WRENDON TIMOTHY
Wrendon Timothy
Chief Financial Officer and Secretary
(Principal Financial Officer and Principal Accounting Officer)

Date: August 8, 2024

Cover - $ / shares	6 Months Ended
Cover - $ / shares	Jun. 30, 2024	Aug. 08, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	1-36346
Entity Registrant Name	OXBRIDGE RE HOLDINGS LIMITED
Entity Central Index Key	0001584831
Entity Tax Identification Number	98-1150254
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	Suite 201
Entity Address, Address Line Two	42 Edward Street, Georgetown
Entity Address, Address Line Three	P.O. Box 469
Entity Address, City or Town	Grand Cayman
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-9006
City Area Code	(345)
Local Phone Number	749-7570
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,036,579
Entity Listing, Par Value Per Share	$ 0.001

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments:
Equity securities, at fair value (cost: $1,563 and $1,926)	$ 213	$ 680
Cash and cash equivalents	3,594	495
Restricted cash and cash equivalents	391	3,250
Premiums receivable	2,118	977
Other Investments	965	2,478
Loan Receivable		100
Due from Related Party	63	63
Deferred policy acquisition costs	240	101
Operating lease right-of-use assets	124	9
Prepayment and other assets	113	96
Property and equipment, net	2	4
Total assets	7,823	8,253
Liabilities and Shareholders’ Equity
Notes payable to noteholders	118	118
Notes payable to Epsilon/DeltaCat Re Tokenholders	1,239	1,523
Unearned Premium Reserve	2,181	915
Operating lease liabilities	124	9
Accounts payable and other liabilities	374	356
Total liabilities	4,036	2,921
Shareholders’ equity:
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,036,579 and 5,870,234 shares issued and outstanding)	6	6
Additional paid-in capital	32,921	32,740
Accumulated Deficit	(29,140)	(27,414)
Total shareholders’ equity	3,787	5,332
Total liabilities and shareholders’ equity	$ 7,823	$ 8,253

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Equity securities, cost	$ 1,563	$ 1,926
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	6,036,579	5,870,234
Common stock, shares outstanding	6,036,579	5,870,234

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Assumed premiums	$ 2,379,000	$ 2,196,000	$ 2,379,000	$ 2,196,000
Change in unearned premiums reserve	(1,815,000)	(2,013,000)	(1,266,000)	(2,013,000)
Net premiums earned	564,000	183,000	1,113,000	183,000
SurancePlus management fee income	312,000	300,000	312,000	300,000
Net investment and other income	65,000	79,000	126,000	168,000
Interest and gain on redemption of loan receivable			41,000
Unrealized (loss) gain on other investments	(825,000)	124,000	(1,513,000)	505,000
Change in fair value of equity securities	(72,000)	5,000	(160,000)	81,000
Total revenue	44,000	691,000	(81,000)	1,237,000
Expenses
Policy acquisition costs and underwriting expenses	62,000	20,000	122,000	20,000
General and administrative expenses	566,000	677,000	1,054,000	1,081,000
Total expenses	628,000	697,000	1,176,000	1,101,000
(Loss) Income before income attributable to noteholders and tokenholders	(584,000)	(6,000)	(1,257,000)	136,000
Income attributable to noteholders and tokenholders	(237,000)	(79,000)	(469,000)	(79,000)
Net (loss) income	$ (821,000)	$ (85,000)	$ (1,726,000)	$ 57,000
(Loss) income per share
(Loss) Income per share, Basic	$ (0.14)	$ (0.01)	$ (0.29)	$ 0.01
(Loss) Income per share, Diluted	$ (0.14)	$ (0.01)	$ (0.29)	$ 0.01
Weighted-average shares outstanding
Weighted average number of shares outstanding, Basic	6,010,561	5,870,234	6,007,868	5,863,973
Weighted average number of shares outstanding, Diluted	6,010,561	5,870,234	6,007,868	5,863,973

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Operating activities
Net (loss) income	$ (821,000)	$ (905,000)	$ (85,000)	$ 142,000	$ (1,726,000)	$ 57,000
Adjustments to reconcile net(loss) income to net cash used in operating activities:
Stock-based compensation					106,000	109,000
Depreciation and amortization					2,000	3,000
SurancePlus management fee income	(312,000)		(300,000)		(312,000)	(300,000)
Change in fair value of other investments	825,000		(124,000)		1,513,000	(505,000)	$ 8,945,000
Change in fair value of equity securities	72,000		(5,000)		160,000	(81,000)
Interest and gain on redemption of loan receivable					(41,000)
Change in operating assets and liabilities:
Accrued interest and dividend receivable						(7,000)
Premiums receivable					(1,141,000)	(1,672,000)
Due from related party						(54,000)
Deferred policy acquisition costs					(139,000)	(221,000)
Prepayment and other assets					(17,000)	29,000
Losses payable						(1,073,000)
Other liablities Cat Re Tokenholders					(1,441,000)	79,000
Unearned premiums reserve					1,266,000	2,013,000
Accounts payable and other liabilities					18,000	9,000
Net cash used in operating activities					(1,752,000)	(1,614,000)
Investing activities
Purchase of property and equipment						(5,000)
Proceeds from redemption of loan receivable					141,000
Proceeds from sale of equity securities					307,000
Net cash provided by (used in) investing activities					448,000	(5,000)
Financing activities
Proceeds from issuance of ordinary shares					75,000
Partial redemption of notes payable to noteholders						(98,000)	(98,000)
Prepaid offering costs						(2,000)
Net proceeds from the issuance of Epsilon/Delta Cat Re tokens					1,469,000	1,280,000
Net cash provided by financing activities					1,544,000	1,180,000
Cash and cash equivalents, and restricted cash and cash equivalents:
Net change during the period					240,000	(439,000)
Balance at beginning of period		$ 3,745,000		$ 3,928,000	3,745,000	3,928,000	3,928,000
Balance at end of period	$ 3,985,000		$ 3,489,000		3,985,000	3,489,000	$ 3,745,000
Non-cash investing activities
Right-of-use lease assets obtained in exchange for operating lease liabilities					$ 124,000

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 6	$ 32,482	$ (17,499)	$ 14,989
Balance, shares at Dec. 31, 2022	5,769,587
Net income (loss)			142	142
Stock-based compensation		54		54
Stock-based compensation, shares
Issuance of restricted stock
Issuance of restricted stock, shares	96,647
Balance at Mar. 31, 2023	$ 6	32,536	(17,357)	15,185
Balance, shares at Mar. 31, 2023	5,866,234
Balance at Dec. 31, 2022	$ 6	32,482	(17,499)	14,989
Balance, shares at Dec. 31, 2022	5,769,587
Net income (loss)				57
Balance at Jun. 30, 2023	$ 6	32,591	(17,442)	15,155
Balance, shares at Jun. 30, 2023	5,870,234
Balance at Mar. 31, 2023	$ 6	32,536	(17,357)	15,185
Balance, shares at Mar. 31, 2023	5,866,234
Net income (loss)			(85)	(85)
Stock-based compensation		55		55
Stock-based compensation, shares	4,000
Balance at Jun. 30, 2023	$ 6	32,591	(17,442)	15,155
Balance, shares at Jun. 30, 2023	5,870,234
Balance at Dec. 31, 2023	$ 6	32,740	(27,414)	5,332
Balance, shares at Dec. 31, 2023	5,870,234
Net income (loss)			(905)	(905)
Stock-based compensation		72		72
Issuance of restricted stock
Issuance of restricted stock, shares	136,427
Balance at Mar. 31, 2024	$ 6	32,812	(28,319)	4,499
Balance, shares at Mar. 31, 2024	6,006,661
Balance at Dec. 31, 2023	$ 6	32,740	(27,414)	5,332
Balance, shares at Dec. 31, 2023	5,870,234
Net income (loss)				(1,726)
Balance at Jun. 30, 2024	$ 6	32,921	(29,140)	3,787
Balance, shares at Jun. 30, 2024	6,036,579
Balance at Mar. 31, 2024	$ 6	32,812	(28,319)	4,499
Balance, shares at Mar. 31, 2024	6,006,661
Net income (loss)			(821)	(821)
Stock-based compensation		34		34
Issuance of ordinary shares		75		75
Issuance of at-the-market stock, shares	29,918
Balance at Jun. 30, 2024	$ 6	$ 32,921	$ (29,140)	$ 3,787
Balance, shares at Jun. 30, 2024	6,036,579

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (821)	$ (905)	$ (85)	$ 142	$ (1,726)	$ 57

ORGANIZATION AND BASIS OF PRESENTATION

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

ORGANIZATION AND BASIS OF PRESENTATION

1. ORGANIZATION AND BASIS OF PRESENTATION

(a) Organization

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

Below is an organizational chart of the Company.

(b) Basis of Presentation and Consolidation

All significant intercompany balances and transactions have been eliminated.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

2. SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

Level 1	Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

Level 2	Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and

Level 3	Inputs that are unobservable.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Fair value measurement (cont’d)

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Accounting Updates:

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

6 Months Ended

Jun. 30, 2024

Cash and Cash Equivalents [Abstract]

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

3. CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

	At June 30,		At December 31,
	2024		2023
	(in thousands)

Cash on deposit	$	3,594	$	495
Restricted cash held in trust		391		3,250
Total	$	3,985	$	3,745

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

INVESTMENTS

6 Months Ended

Jun. 30, 2024

Investments, All Other Investments [Abstract]

INVESTMENTS

4. INVESTMENTS

Gross

proceeds

Realized

from sales

Gains

Losses

($ in thousands)

Six Months Ended June 30, 2024

Equity securities

307

Other Investments

Other investments as of June 30, 2024 and December 31, 2023 consist of the following (in thousands):

SCHEDULE OF OTHER INVESTMENT

	June 30, 2024			December 31, 2023
Jet.AI. Series A-1 Preferred Shares	$	285		$	285
Jet.AI common stock		680			2,193
Total	$	965		$	2,478

Beginning of year		2,478			11,423
Unrealized loss on investment in affiliate		(1,513	)		(8,945	)
End of year	$	965		$	2,478

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

4. INVESTMENTS (continued)

Assets Measured at Estimated Fair Value on a Recurring Basis


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of June 30, 2024	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	3,594	$	-	$	-	$	3,594

Restricted cash and cash equivalents	$	391	$	-	$	-	$	391

Other investments	$	680	$	-	$	285	$	965

Equity securities	$	213	$	-	$	-	$	213

Total	$	4,878	$	-	$	285	$	4,878


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of December 31, 2023	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	495	$	-	$	-	$	495

Restricted cash and cash equivalents	$	3,250	$	-	$	-	$	3,250

Other investments	$	2,193	$	-	$	285	$	2,478

Equity securities	$	680	$	-	$	-	$	680

Total	$	6,618	$	-	$	285	$	6,903

There were no transfers between Levels 1, 2 or 3 during the three and six months ended June 30, 2024 and 2023.

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

	Other
	Investments
	(in thousands)
Fair value of Level 3 other investment at January 1, 2024	$	285
Investment in affiliate		-
Change in valuation inputs or other assumptions		-
Fair value of Level 3 other investment at June 30, 2024	$	285

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

TAXATION

6 Months Ended

Jun. 30, 2024

Income Tax Disclosure [Abstract]

TAXATION

5. TAXATION

VARIABLE INTEREST ENTITIES

6 Months Ended

Jun. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

VARIABLE INTEREST ENTITIES

6. VARIABLE INTEREST ENTITIES

In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.

The Company receives an origination and structuring fee in connection with the formation, operation and management of Oxbridge Re NS.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

6. VARIABLE INTEREST ENTITIES (continued)

Notes Payable to Series 2020-1 noteholders

The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the six-months ended June 30, 2024 and 2023 was $0.

SurancePlus Inc.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

6. VARIABLE INTEREST ENTITIES (continued)

SCHEDULE OF FINANCIAL STATEMENTS

Statement of Operations Data:	For Three Months Ended			For Six Months Ended
	June 30, 2024			June 30, 2024
	(Unaudited)			(Unaudited)

Management fee income	$	611		$	612
Underwriting related income		502			991
Net Investment and Other Income		5			5
Total revenue	$	1,118		$	1,608
Expenses	$	(127	)	$	(141	)
Income attributable to tokenholders	$	(457	)	$	(901	)
Net income		534			566

Balance Sheet Data:	At June 30, 2024
	(Unaudited)
	(In thousands)
Total assets	$	3,811
Amounts due to Cat Re Tokenholders*		1,318
Total shareholder’s equity		2,420

*	includes underwriting profit of $78,000 due to Parent.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

6 Months Ended

Jun. 30, 2024

Reserve For Losses And Loss Adjustment Expenses

RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

SCHEDULE OF LOSS ADJUSTMENT EXPENSE

		At June 30,		At June 30,
		2024		2023
		(in thousands)

Balance, beginning of period	$	-	$	1,073
Incurred related to:
Current period		-		-
Prior period		-		-
Total incurred		-		1,073
Paid related to:
Current period		-		(1,073	)
Prior period		-		-
Total paid		-		(1,073	)
Balance, end of period	$	-	$	-

The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.

There were no losses incurred during the six-month periods ended June 30, 2024 and 2023.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

(LOSS) EARNINGS PER SHARE

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

(LOSS) EARNINGS PER SHARE

8. (LOSS) EARNINGS PER SHARE

A summary of the numerator and denominator of the basic and diluted (loss) earnings per share is presented below (dollars in thousands except per share amounts):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023

Numerator:
Net (loss) income	$	(821	)		(85	)	$	(1,726	)		57

Denominator:
Weighted average shares - basic		6,010,561			5,870,234			6,007,868			5,863,973
Weighted average shares - diluted		6,010,561			5,870,234			6,007,868			5,863,973
(Loss) earnings per share - basic	$	(0.14	)		(0.01	)	$	(0.29	)		0.01
(Loss) earnings per share - diluted	$	(0.14	)		(0.01	)	$	(0.29	)		0.01

WARRANTS

6 Months Ended

Jun. 30, 2024

Warrants

WARRANTS

9. WARRANTS

DIVIDENDS

6 Months Ended

Jun. 30, 2024

Dividends

DIVIDENDS

10. DIVIDENDS

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

SHARE-BASED COMPENSATION

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

SHARE-BASED COMPENSATION

11. SHARE-BASED COMPENSATION

Stock options

Stock options granted and outstanding under the Plan vests quarterly over four years and are exercisable over the contractual term of ten years.

A summary of the stock option activity for the six-month periods ended June 30, 2024 and 2023 is as follows:

SCHEDULE OF STOCK OPTION ACTIVITY

						Weighted-
				Weighted-		Average
	Number			Average		Remaining		Aggregate
	of			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value

Outstanding at January 1, 2023		871,250			4.67		5.6 years		-
Forfeited		(25,000	)	$	6.00
Outstanding at March 31, 2023		846,250		$	4.63		5.5 years		-
Exercisable at March 31, 2023		736,875		$	4.43		5.2 years		-
Outstanding at June 30, 2023		846,250		$	4.63		5.3 years	$	-
Exercisable at June 30, 2023		752,500		$	4.46		5.0 years	$	-
Outstanding at January 1, 2024		846,250		$	4.63		4.8 years	$	-
Outstanding at March 31, 2024		846,250		$	4.63		4.5 years	$	-
Exercisable at March 31, 2024		799,375		$	4.55		4.4 years	$	-
Outstanding at June 30, 2024		846,250		$	4.63		4.3 years	$	-
Exercisable at June 30, 2024		815,000		$	4.58		4.2 years	$	-

Restricted Stock Awards

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

11. SHARE-BASED COMPENSATION (cont’d)

Restricted stock awards (continued)

	Weighted-
	Number of			Weighted-
	Restricted			Average
	Stock			Grant Date
	Awards			Fair Value

Nonvested at January 1, 2024		46,073		$	1.05
Granted		136,427		$	1.05
Vested		(53,074	)	$	1.05
Nonvested at June 30, 2024		129,426

Subsidiary Equity Plan

NET WORTH FOR REGULATORY PURPOSES

6 Months Ended

Jun. 30, 2024

Net Worth For Regulatory Purposes

NET WORTH FOR REGULATORY PURPOSES

12. NET WORTH FOR REGULATORY PURPOSES

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES

13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES)

Fair values

Concentration of underwriting risk

Concentrations of Credit and Counterparty Risk

Market risk

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

LEASES

6 Months Ended

Jun. 30, 2024

Leases

LEASES

14. LEASES

The components of lease expense and other lease information as of and during the six-month periods ended June 30, 2024 and 2023 are as follows:

SCHEDULE OF OPERATING LEASE COST


	For the Six- Month Period		For the Six- Month Period
(in thousands)	Ended June 30, 2024		Ended June 30, 2023
Operating Lease Cost ⁽¹⁾	$	53	$	50

Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	53	$	50

(1)	Includes short-term leases

SCHEDULE OF OPERATING LEASE OBLIGATIONS

(in thousands)	At June 30, 2024			At December 31, 2023
Operating lease right-of-use assets	$	124		$	9

Operating lease liabilities	$	124		$	9

Weighted-average remaining lease term - operating leases		2.13 years			0.39 years

Weighted-average discount rate - operating leases		9.25	%		7.13%

(in thousands)	At June 30, 2024			At December 31, 2023
Remainder of 2024	$	53		$	9
2025		39			-
2026		39			-
Thereafter		6			-
Total future minimum lease payments	$	137		$	9

Less imputed interest		(13	)		-
Total operating lease liability	$	124		$	9

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

RELATED PARTY TRANSACTIONS

6 Months Ended

Jun. 30, 2024

RELATED PARTY TRANSACTIONS

15. RELATED PARTY TRANSACTIONS

Epsilon Re Tokens

TypTap Insurance Company (“TypTap”) Contract

Bridge Loan with Affiliate

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

16. SUBSEQUENT EVENTS

We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements.

ATM Facility

Warrant Conversion

SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

Cash and cash equivalents

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

Restricted cash and cash equivalents

Investments

Fair value measurement

Level 1	Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

Level 2	Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and

Level 3	Inputs that are unobservable.

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Fair value measurement (cont’d)

Deferred policy acquisition costs (“DAC”)

Offering Expenses

Reserves for losses and loss adjustment expenses

Loss experience refund payable

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Premiums assumed

Unearned Premiums Ceded

Uncertain Income Tax Positions

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

June 30, 2024

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

(Loss) Earnings Per Share

Share-Based Compensation

Accounting Updates

Accounting Updates:

Segment Information

Reclassifications

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables)

6 Months Ended

Jun. 30, 2024

Cash and Cash Equivalents [Abstract]

SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

	At June 30,		At December 31,
	2024		2023
	(in thousands)

Cash on deposit	$	3,594	$	495
Restricted cash held in trust		391		3,250
Total	$	3,985	$	3,745

INVESTMENTS (Tables)

6 Months Ended

Jun. 30, 2024

Investments, All Other Investments [Abstract]

SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES

Gross

proceeds

Realized

from sales

Gains

Losses

($ in thousands)

Six Months Ended June 30, 2024

Equity securities

307

SCHEDULE OF OTHER INVESTMENT

Other investments as of June 30, 2024 and December 31, 2023 consist of the following (in thousands):

SCHEDULE OF OTHER INVESTMENT

	June 30, 2024			December 31, 2023
Jet.AI. Series A-1 Preferred Shares	$	285		$	285
Jet.AI common stock		680			2,193
Total	$	965		$	2,478

Beginning of year		2,478			11,423
Unrealized loss on investment in affiliate		(1,513	)		(8,945	)
End of year	$	965		$	2,478

SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of June 30, 2024	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	3,594	$	-	$	-	$	3,594

Restricted cash and cash equivalents	$	391	$	-	$	-	$	391

Other investments	$	680	$	-	$	285	$	965

Equity securities	$	213	$	-	$	-	$	213

Total	$	4,878	$	-	$	285	$	4,878


	Fair Value Measurements Using
	(Level 1)		(Level 2)		(Level 3)		Total
As of December 31, 2023	($ in thousands)
Financial Assets:
Cash and cash equivalents	$	495	$	-	$	-	$	495

Restricted cash and cash equivalents	$	3,250	$	-	$	-	$	3,250

Other investments	$	2,193	$	-	$	285	$	2,478

Equity securities	$	680	$	-	$	-	$	680

Total	$	6,618	$	-	$	285	$	6,903

SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

	Other
	Investments
	(in thousands)
Fair value of Level 3 other investment at January 1, 2024	$	285
Investment in affiliate		-
Change in valuation inputs or other assumptions		-
Fair value of Level 3 other investment at June 30, 2024	$	285

VARIABLE INTEREST ENTITIES (Tables)

6 Months Ended

Jun. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

SCHEDULE OF FINANCIAL STATEMENTS

Statement of Operations Data:	For Three Months Ended			For Six Months Ended
	June 30, 2024			June 30, 2024
	(Unaudited)			(Unaudited)

Management fee income	$	611		$	612
Underwriting related income		502			991
Net Investment and Other Income		5			5
Total revenue	$	1,118		$	1,608
Expenses	$	(127	)	$	(141	)
Income attributable to tokenholders	$	(457	)	$	(901	)
Net income		534			566

Balance Sheet Data:	At June 30, 2024
	(Unaudited)
	(In thousands)
Total assets	$	3,811
Amounts due to Cat Re Tokenholders*		1,318
Total shareholder’s equity		2,420

*	includes underwriting profit of $78,000 due to Parent.

RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables)

6 Months Ended

Jun. 30, 2024

Reserve For Losses And Loss Adjustment Expenses

SCHEDULE OF LOSS ADJUSTMENT EXPENSE

		At June 30,		At June 30,
		2024		2023
		(in thousands)

Balance, beginning of period	$	-	$	1,073
Incurred related to:
Current period		-		-
Prior period		-		-
Total incurred		-		1,073
Paid related to:
Current period		-		(1,073	)
Prior period		-		-
Total paid		-		(1,073	)
Balance, end of period	$	-	$	-

(LOSS) EARNINGS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE

A summary of the numerator and denominator of the basic and diluted (loss) earnings per share is presented below (dollars in thousands except per share amounts):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023

Numerator:
Net (loss) income	$	(821	)		(85	)	$	(1,726	)		57

Denominator:
Weighted average shares - basic		6,010,561			5,870,234			6,007,868			5,863,973
Weighted average shares - diluted		6,010,561			5,870,234			6,007,868			5,863,973
(Loss) earnings per share - basic	$	(0.14	)		(0.01	)	$	(0.29	)		0.01
(Loss) earnings per share - diluted	$	(0.14	)		(0.01	)	$	(0.29	)		0.01

SHARE-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity for the six-month periods ended June 30, 2024 and 2023 is as follows:

SCHEDULE OF STOCK OPTION ACTIVITY

						Weighted-
				Weighted-		Average
	Number			Average		Remaining		Aggregate
	of			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value

Outstanding at January 1, 2023		871,250			4.67		5.6 years		-
Forfeited		(25,000	)	$	6.00
Outstanding at March 31, 2023		846,250		$	4.63		5.5 years		-
Exercisable at March 31, 2023		736,875		$	4.43		5.2 years		-
Outstanding at June 30, 2023		846,250		$	4.63		5.3 years	$	-
Exercisable at June 30, 2023		752,500		$	4.46		5.0 years	$	-
Outstanding at January 1, 2024		846,250		$	4.63		4.8 years	$	-
Outstanding at March 31, 2024		846,250		$	4.63		4.5 years	$	-
Exercisable at March 31, 2024		799,375		$	4.55		4.4 years	$	-
Outstanding at June 30, 2024		846,250		$	4.63		4.3 years	$	-
Exercisable at June 30, 2024		815,000		$	4.58		4.2 years	$	-

SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS

	Weighted-
	Number of			Weighted-
	Restricted			Average
	Stock			Grant Date
	Awards			Fair Value

Nonvested at January 1, 2024		46,073		$	1.05
Granted		136,427		$	1.05
Vested		(53,074	)	$	1.05
Nonvested at June 30, 2024		129,426

LEASES (Tables)

6 Months Ended

Jun. 30, 2024

Leases

SCHEDULE OF OPERATING LEASE COST

The components of lease expense and other lease information as of and during the six-month periods ended June 30, 2024 and 2023 are as follows:

SCHEDULE OF OPERATING LEASE COST


	For the Six- Month Period		For the Six- Month Period
(in thousands)	Ended June 30, 2024		Ended June 30, 2023
Operating Lease Cost ⁽¹⁾	$	53	$	50

Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	53	$	50

(1)	Includes short-term leases

SCHEDULE OF OPERATING LEASE OBLIGATIONS

(in thousands)	At June 30, 2024			At December 31, 2023
Operating lease right-of-use assets	$	124		$	9

Operating lease liabilities	$	124		$	9

Weighted-average remaining lease term - operating leases		2.13 years			0.39 years

Weighted-average discount rate - operating leases		9.25	%		7.13%

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS

(in thousands)	At June 30, 2024			At December 31, 2023
Remainder of 2024	$	53		$	9
2025		39			-
2026		39			-
Thereafter		6			-
Total future minimum lease payments	$	137		$	9

Less imputed interest		(13	)		-
Total operating lease liability	$	124		$	9

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)	Dec. 19, 2022	Dec. 22, 2017	Apr. 23, 2013
Oxbridge Reinsurance Limited [Member]
Ownership percentage			100.00%
Oxbridge Re NS [Member]
Ownership percentage		100.00%
Surance Plus Inc [Member]
Ownership percentage	100.00%

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	Jun. 30, 2024 USD ($)
Maximum [Member] \| Equity Distribution Agreement [Member]
Property, Plant and Equipment [Line Items]
Aggregate offering price	$ 6,300,000
Maximum [Member] \| Equity Distribution Agreement [Member] \| EpsilonCat Re Digital Tokens [Member]
Property, Plant and Equipment [Line Items]
Aggregate offering price	5,000,000
Surance Plus Inc [Member]
Property, Plant and Equipment [Line Items]
Offering expenses	$ 140,000

SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Cash and Cash Equivalents [Abstract]
Cash on deposit	$ 3,594	$ 495
Restricted cash held in trust	391	3,250
Total	$ 3,985	$ 3,745

SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Investments, All Other Investments [Abstract]
Gross proceeds from sales	$ 307
Gross Realized Gains
Gross Realized Losses

SCHEDULE OF OTHER INVESTMENT (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
SCHEDULE OF OTHER INVESTMENT (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Total	$ 965,000		$ 965,000		$ 2,478,000
Beginning of year			2,478,000	$ 11,423,000	11,423,000
Unrealized loss on other investments	(825,000)	$ 124,000	(1,513,000)	$ 505,000	(8,945,000)
End of period	965,000		965,000		2,478,000
Jet.AI. Series A-1 Preferred Shares [Member]
Defined Benefit Plan Disclosure [Line Items]
Total	285,000		285,000		285,000
Beginning of year			285,000
End of period	285,000		285,000		285,000
Jet.AI Common Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Total	680,000		680,000		2,193,000
Beginning of year			2,193,000
End of period	$ 680,000		$ 680,000		$ 2,193,000

SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Platform Operator, Crypto Asset [Line Items]
Cash and cash equivalents	$ 3,594	$ 495
Restricted cash and cash equivalents	391	3,250
Other investments	965	2,478	$ 11,423
Equity securities	213	680
Total	4,878	6,903
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Cash and cash equivalents	3,594	495
Restricted cash and cash equivalents	391	3,250
Other investments	680	2,193
Equity securities	213	680
Total	4,878	6,618
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Cash and cash equivalents
Restricted cash and cash equivalents
Other investments
Equity securities
Total
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Cash and cash equivalents
Restricted cash and cash equivalents
Other investments	285	285
Equity securities
Total	$ 285	$ 285

SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Platform Operator, Crypto Asset [Line Items]
Fair value of Level 3 other investment, Beginning balance	$ 285
Investment in affiliate
Change in valuation inputs or other assumptions
Fair value of Level 3 other investment, Ending balance	$ 285

INVESTMENTS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
INVESTMENTS (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Unrealized loss on other investments	$ 825,000	$ (124,000)	$ 1,513,000	$ (505,000)	$ 8,945,000
Oxbridge Acquisition Corp [Member]
Number of shares issued			2,875,000
Oxbridge Acquisition Corp [Member] \| Warrant [Member]
Number of warrants shares	4,897,500		4,897,500
Oxbridge Acquisition Corp [Member] \| Series A-1 Preferred Stock [Member]
Number of shares issued			575
Price per share	$ 1,000		$ 1,000

SCHEDULE OF FINANCIAL STATEMENTS (Details) - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2024

Mar. 31, 2024

Jun. 30, 2023

Mar. 31, 2023

Jun. 30, 2024

Jun. 30, 2023

Dec. 31, 2023

Dec. 31, 2022

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Total revenue

$ 44

$ 691

$ (81)

$ 1,237

Income attributable to tokenholders

(584)

(6)

(1,257)

136

Net (loss) income

(821)

$ (905)

(85)

$ 142

(1,726)

Total assets

7,823

$ 8,253

Total shareholder’s equity

3,787

$ 4,499

$ 15,155

$ 15,185

3,787

$ 15,155

$ 5,332

$ 14,989

Underwriting Income (Loss)

78,000

Surance Plus Inc [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Total revenue

1,118

1,608

Expenses

(127)

(141)

Income attributable to tokenholders

(457)

(901)

Net (loss) income

534

566

Total assets

3,811

Total shareholder’s equity

2,420

Surance Plus Inc [Member] | Related Party [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Amounts due to Cat Re Tokenholders

^[1]

1,318

Surance Plus Inc [Member] | Management Fee Income [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Total revenue

611

612

Surance Plus Inc [Member] | Underwriting Related Income [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Total revenue

502

991

Surance Plus Inc [Member] | Net Investment and Other Income [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Total revenue

$ 5

[1]	includes underwriting profit of $78,000 due to Parent.

VARIABLE INTEREST ENTITIES (Details Narrative) - USD ($)						3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 11, 2024	Mar. 18, 2024	Jun. 27, 2023	Mar. 27, 2023	Jun. 01, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 22, 2017
Repayments of notes									$ 98,000	$ 98,000
Convertible notes payable current						$ 118,000		118,000		$ 118,000
Management fee						312,000	$ 300,000	312,000	300,000
Stock issued during period, value, new issues						$ 75,000
Surance Plus Inc [Member]
Shares issued, price per share		$ 10.00	$ 10.00	$ 10.00
Description for offer and sale of securities		The net proceeds from the offer and sale of the Participation Shares were used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, an affiliated Cayman Islands licensed reinsurance entity, and the proceeds from the sale of such participating notes were invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the Participation Shares will generally be entitled to proceeds from the payment of the participating notes in the amount of a preferred return equal to the initial Participation Share price, plus 20%, and then 80% of any proceeds in excess of the amount necessary to pay the preferred return.		The net proceeds from the offer and sale of the Securities were used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes were invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return
Number of shares issued			244,776
Proceeds from issuance of private placement			$ 2,447,760
Number of shares issued		1,000,000
Surance Plus Inc [Member] \| Parent [Member]
Proceeds from issuance of private placement			1,167,000
Management fee			273,000
Surance Plus Inc [Member] \| Third Party Investors [Member]
Proceeds from issuance of private placement			1,280,000
Management fee			300,000
Surance Plus Inc [Member] \| Subscription agreements [Member]
Proceeds from issuance of private placement			$ 150,100
Surance Plus Inc [Member] \| Subscription Arrangements [Member] \| Parent [Member] \| Subsequent Event [Member]
Proceeds from issuance of private placement	$ 1,409,000
Management fee	299,000
Surance Plus Inc [Member] \| Subscription Arrangements [Member] \| Third Party Investors [Member] \| Subsequent Event [Member]
Proceeds from issuance of private placement	1,469,000
Management fee	312,000
Surance Plus Inc [Member] \| Investors and non US persons [Member] \| Subscription agreements [Member]
Shares issued, price per share			$ 10.00
Number of shares issued			229,766
Proceeds from issuance of private placement			$ 2,297,660
Sale of stock number of shares issued in transaction			15,010
Surance Plus Inc [Member] \| Investors and non US persons [Member] \| Subscription Arrangements [Member] \| Subsequent Event [Member]
Proceeds from issuance of private placement	2,878,048
Stock issued during period, value, new issues	$ 287,705
Share price	$ 10.00
Notes Payable to Series 2020 -1 Noteholders [Member]
Notes issued					$ 216,000
Debt maturity date					Jun. 01, 2023
Oxbridge Re NS [Member]
Ownership percentage											100.00%
Income from operations								$ 0	$ 0

SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Reserve For Losses And Loss Adjustment Expenses
Balance, beginning of period		$ 1,073
Current period
Prior period
Total incurred		1,073
Current period		(1,073)
Prior period
Total paid		(1,073)
Balance, end of period

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net (loss) income	$ (821)	$ (905)	$ (85)	$ 142	$ (1,726)	$ 57
Weighted average shares - basic	6,010,561		5,870,234		6,007,868	5,863,973
Weighted average shares - diluted	6,010,561		5,870,234		6,007,868	5,863,973
(Loss) earnings per share - basic	$ (0.14)		$ (0.01)		$ (0.29)	$ 0.01
(Loss) earnings per share - diluted	$ (0.14)		$ (0.01)		$ (0.29)	$ 0.01

(LOSS) EARNINGS PER SHARE (Details Narrative) - shares	3 Months Ended		6 Months Ended
(LOSS) EARNINGS PER SHARE (Details Narrative) - shares	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of anti-dilutive ordinary shares	846,250	846,250		846,250
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of anti-dilutive ordinary shares	8,230,700	8,230,700		8,230,700
Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of anti-dilutive ordinary shares		8,230,700	8,230,700	8,230,700

WARRANTS (Details Narrative) - $ / shares	6 Months Ended
WARRANTS (Details Narrative) - $ / shares	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Warrants exercised	0	0
Warrant [Member]
Warrant outstanding	8,230,700		8,230,700
Exercise price	$ 7.50
Common Stock [Member]
Closing price per share	$ 9.38

SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Number of Options, Outstanding, Balance	846,250	871,250	846,250	871,250	871,250
Weighted-Average Exercise Price, Outstanding, Balance	$ 4.63	$ 4.67	$ 4.63	$ 4.67	$ 4.67
Weighted-Average Remaining Contractual Term, Outstanding	4 years 6 months	5 years 6 months	4 years 3 months 18 days	5 years 3 months 18 days	4 years 9 months 18 days	5 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding, Balance
Number of Options, Forfeited		(25,000)
Weighted-Average Exercise Price, Forfeited		$ 6.00
Number of Options Outstanding, Balance	846,250	846,250	846,250	846,250	846,250	871,250
Weighted-Average Exercise Price, Outstanding, Balance	$ 4.63	$ 4.63	$ 4.63	$ 4.63	$ 4.63	$ 4.67
Aggregate Intrinsic Value, Outstanding, Balance
Number of Options Exercisable, Balance	799,375	736,875	815,000	752,500
Weighted-Average Exercise Price, Exercisable, Balance	$ 4.55	$ 4.43	$ 4.58	$ 4.46
Weighted-Average Remaining Contractual Term, Exercisable	4 years 4 months 24 days	5 years 2 months 12 days	4 years 2 months 12 days	5 years
Aggregate Intrinsic Value, Exercisable, Balance

SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details) - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Weighted-Number of Restricted Stock Awards, Beginning balance	46,073
Weighted-Average Grant Date Fair Value, Beginning balance	$ 1.05
Weighted-Number of Restricted Stock Awards, Granted	136,427	100,647
Weighted-Average Grant Date Fair Value, Granted	$ 1.05
Weighted-Number of Restricted Stock Awards, Vested	(53,074)
Weighted-Average Grant Date Fair Value, Vested	$ 1.05
Weighted-Number of Restricted Stock Awards, Ending balance	129,426

SHARE-BASED COMPENSATION (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)	Mar. 25, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted-number of restricted stock awards				136,427	100,647
Vesting period, contractual term				10 years
Unrecognized compensation		$ 10,000	$ 30,000	$ 10,000	$ 30,000
Surance Plus Holdings Ltd [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based payment award options grants in period gross	750,000
Employees aggregate shares purchase	200,000
Share based payment award options grants in period gross	548,100
Granted exercise price	$ 15
General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense		5,000	4,000	15,000	10,000
Restricted Stock [Member] \| General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense		29,000	$ 50,000	91,000	$ 99,000
Unrecognized compensation		$ 192,000		$ 192,000
2014 Omnibus Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based payment award options grants in period gross				1,000,000
Shares available for grant		11,750		11,750
2021 Omnibus Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares available for grant		758,926		758,926
2021 Omnibus Incentive Plan [Member] \| Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted-number of restricted stock awards				136,429

NET WORTH FOR REGULATORY PURPOSES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Minimum prescribed capital requirement description			Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.
Oxbridge Reinsurance Limited [Member]
Subsidiary net worth	$ 7,000		$ 7,000
Net income			2,100,000	$ 420,000
Oxbridge Re NS [Member]
Subsidiary net worth	303,000		303,000
Net income	$ 79,000		$ 79,000

SCHEDULE OF OPERATING LEASE COST (Details) - USD ($)
$ in Thousands

6 Months Ended

Jun. 30, 2024

Jun. 30, 2023

Leases

Operating Lease Cost

^[1]

$ 53

$ 50

Operating cash flows from operating leases

$ 53

$ 50

[1]	Includes short-term leases

SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases
Operating lease right-of-use assets	$ 124	$ 9
Operating lease liabilities	$ 124	$ 9
Weighted-average remaining lease term - operating leases	2 years 1 month 17 days	4 months 20 days
Weighted-average discount rate - operating leases	9.25%	7.13%

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases
Remainder of 2024	$ 53	$ 9
2025	39
2026	39
Thereafter	6
Total future minimum lease payments	137	9
Less imputed interest	(13)
Total operating lease liability	$ 124	$ 9

LEASES (Details Narrative)	6 Months Ended
LEASES (Details Narrative)	Jun. 30, 2024
Office Lease [Member]
Lessee, Lease, Description [Line Items]
Remaining lease term	32 months
Lease termination, description	the Company also has the right to terminate the lease after thirty-six (36) months upon giving appropriate notice in writing to the Lessor.
Residential Lease [Member]
Lessee, Lease, Description [Line Items]
Remaining lease term	6 months

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Sep. 11, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 11, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Premiums receivable, net		$ 2,118,000		$ 2,118,000			$ 977,000
Deferred policy acquisition cost		240,000		240,000			101,000
Unearned premiums		2,181,000		2,181,000			$ 915,000
Increase (decrease) in premiums receivable				1,141,000	$ 1,672,000
Foreign reinsurance transactions, expense additions to underwriting balances		62,000	$ 20,000	122,000	$ 20,000
Policy loans receivable		100,000		100,000
Redemption of notes payable						$ 141,000
Reinsurance Agreement [Member]
Related Party Transaction [Line Items]
Premiums receivable, net		893,000		893,000
Deferred policy acquisition cost		101,000		101,000
Unearned premiums		920,000		920,000
Increase (decrease) in premiums receivable		1,004,000		1,004,000
Deferred policy acquisition cost, capitalization		462,000		462,000
Foreign reinsurance transactions, expense additions to underwriting balances		$ 59,000		$ 59,000
Bridge Agreement [Member] \| Investor [Member]
Related Party Transaction [Line Items]
Short-term bridge funds	$ 500,000
Debt face amount	$ 625,000
Percentage of original issue discount	20.00%
Notes interest rate	5.00%
Debt instrument, maturity date	Mar. 11, 2024
Debt, description	Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes.
Mr Jay Madhu [Member]
Related Party Transaction [Line Items]
Number of shares issued				9,245
Shares issued, price per share		$ 10.00		$ 10.00
Aggregate purchase price				$ 92,447

SUBSEQUENT EVENTS (Details Narrative) - USD ($)				1 Months Ended	3 Months Ended		6 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jul. 29, 2024	Jul. 11, 2024	Jun. 27, 2023	Aug. 08, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 18, 2024	Mar. 27, 2023
Subsequent Event [Line Items]
Stock issued during period, value, new issues					$ 75,000
Management fee					312,000	$ 300,000	$ 312,000	$ 300,000
Common Stock [Member]
Subsequent Event [Line Items]
Stock issued during period, value, new issues
Share price					$ 9.38		$ 9.38
Surance Plus Inc [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement			$ 2,447,760
Oridinary per share			$ 10.00						$ 10.00	$ 10.00
Surance Plus Inc [Member] \| Parent [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement			$ 1,167,000
Management fee			273,000
Surance Plus Inc [Member] \| Third Party Investors [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement			1,280,000
Management fee			$ 300,000
Subsequent Event [Member] \| Warrant [Member]
Subsequent Event [Line Items]
Warrants converted, shares	3,094,999
Subsequent Event [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Shares issued after convertion. shares	945,211
Subscription Arrangements [Member] \| Subsequent Event [Member] \| Surance Plus Inc [Member] \| Parent [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement		$ 1,409,000
Management fee		299,000
Subscription Arrangements [Member] \| Subsequent Event [Member] \| Surance Plus Inc [Member] \| Third Party Investors [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement		1,469,000
Management fee		312,000
Subscription Arrangements [Member] \| Investors and non US persons [Member] \| Subsequent Event [Member] \| Surance Plus Inc [Member]
Subsequent Event [Line Items]
Stock issued during period, value, new issues		$ 287,705
Share price		$ 10.00
Proceeds from issuance of private placement		$ 2,878,048
ATM Offering Agreement [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares sold				131,795
Proceeds from sale of equity				$ 385,365
Oridinary per share				$ 2.92
Commissions paid				$ 11,561
Net proceeds transactions value				$ 373,804